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Suprachiasmatic nuclei (SCN) is the master circadian pacemaker that generates
coordinated rhythms and drives oscillations in other peripheral tissues. Extracellular
vesicles (exosomes) have been implicated in cell-to-cell communication and the
regulation of circadian clock. However, mammalian clock-derived exosomes have not
been characterized. This thesis examine the contents of exosome released from SCN2.2
cells in vitro using a combination of proteomics, next-generation sequencing, and
bioinformatic analyses. SCN2.2 cells-derived exosomes, that carry unique microRNAs
and proteins, could be taken up by fibroblast cells in vitro. Interestingly, several unique
microRNAs and proteins found in SCN2.2 cells-derived exosomes have shown circadian
rhythmicity in other cells. In addition, differential expressed microRNAs secreted by
SCN cells were also observed outside of exosomes. Taken together, these studies
demonstrate that exosomes, containing small RNAs, RNAs and proteins, are released
from SCN2.2 cells and likely have a biological role in circadian regulation of
metabolism in downstream cells.
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CHAPTER I
INTRODUCTION

1.1

Biological rhythms
Biological rhythms are widely spread in prokaryotes such as cyanobacteria and

eukaryotes such as fungi, plants and mammals (Webb and Oates, 2015; Aschoff, 1981).
Biological rhythms also perform in single cells, tissues, and organs of one single body, as
well as in the whole organism or in populations. Biological rhythms allow creatures to
form a temporal organization of their behavior and metabolism in advantageous ways. In
1935, Kalmus defined the biological rhythm as the recurrence of any event within a
biological system at more-or-less regular intervals, such as firing of cold receptor repeats
per 100 millisecond in cats (Hensel and Zotterman, 1951), bursts of locomotor activity
repeats per 2h of Microtus arvalis (Daan and Slopsema, 1978), oxygen uptake repeats per
24h of Peromyscus maniculatus (Heusner et al., 1971), and fur returns repeats per 10
years of Lynx canadensis (Elton and Nicholson, 1942).
There are two basic concepts that need to be understood in biological rhythms:
rhythm and phase. First, rhythm shows repetitive events with regular periods that are
controlled by a pacemaker. There are several restrictive descriptions used to classify
rhythms: a characteristic (such as frequency) that involves logarithmic units; the
biological systems in which the rhythm is observed; the kind of process that generates the
rhythm; and finally, the function that the rhythm fulfills. Second, phase represents the
1

transient change in the cycle period of an oscillation. This change is induced by a
perturbation of the rhythm. Phase response curve analysis, which was first published in
1960 by Patricia DeCoursey, can be used to understand the intrinsic properties and
oscillatory behavior of regular spiking neurons (Gutkin et al., 2005).
Neuromas studies have shown that biological rhythms are endogenous rhythms
that adjust to external signals, which include light, dark, temperature, food, season, area,
or sunspot (Nicholson, 1954). There are four endogenous rhythms that correspond to
cycles in the environment: circadian (which means daily rhythm), circatidal (which
means tidal rhythm), circalunar (which means lunar rhythm), and circannual (which
means seasonal rhythm) (Ashoff, 1967). The prefix “circa,” meaning “about,” was first
advanced by Halberg in 1958. Much research has shown that there is a hierarchical order
among rhythms, and one rhythm is essential for the proper action of another rhythm. A
typical example of this phenomenon is the interaction between the circadian system and
the estrous cycle in hamsters.
The circadian rhythm is the most researched and, as such, it is subdivided into
ultradian rhythms that have periods shorter than circadian, such as the repetition of phase
of rapid eye movements during sleep, and infradian rhythms that have periods longer than
circadian, such as the enzyme activity of the rat pineal (Halberg et al., 1965; Vollrath et
al., 1975). The circadian clock is the best understood of the biological rhythms, and it
orchestrates the sleep/wake cycle of organisms. The molecular architecture of the
circadian clock is discussed in 1.2.4.

2

1.2

Mammalian circadian rhythm
The earth rotates around its axis about 24 hours per cycle. With creatures’

evolution, the biological mechanisms that coordinate organisms’ internal events and
external behaviors were formed to follow the earth rotation, which have been named
circadian rhythms. So circadian rhythms have a cycle about 24h and an endogenous
oscillation, their Latin name is circadiem: circa means “about” and diem means “day”
(Turek, 1985). Circadian rhythms are intrinsic rhythms, which is entrained to local time
through light input from the light-detecting photoreceptors in the retina (Berson et al.,
2002; Hattar et al., 2002; Lucas et al., 2003). There are some characteristics of circadian
rhythm: 1) the cycle runs with a period close to 24h and persists under constant
conditions, 2) the rhythm can be entrained by environmental changes such as light, 3)
temperature compensation occurs, which means the period of the rhythm doesn’t change
even at different temperatures. Circadian rhythms relate to an organism’s behavior,
physiology, metabolism, and even gene expression.
Human are familiar with clocks. In fact, humans schedule their entire days based
on clocks. For example, students have class the same time of day every week, and adjust
according to that time frame. The human body even has an exact time that it knows to
wake every morning and sleep every night. In multi-cellular animals, circadian
rhythmicity is a universal property of biochemical and physiological processes and is
predominantly controlled by nervous and neuroendocrine structures. According to many
researchers, mammalian circadian rhythms are considered hierarchical organizations with
a master pacemaker – the suprachiasmatic nuclei (SCN) of the hypothalamus in the
central nervous system – and oscillators in peripheral tissues. Despite their similarities at
3

the molecular and cellular levels of organization, the SCN and peripheral oscillators are
fundamentally different. The SCN contains the only known oscillators that can be
directly entrained by light. Photoentrainment signals from the retina are processed
through the retinohypothalamic tract (RHT), which terminates in the SCN. In contrast,
there is currently no data to suggest that peripheral tissues in mammals receive direct
photic input. This suggests a hierarchical model in which the SCN provides a critical link
between the outside world and the internal circadian timekeeping mechanism. This
hierarchical organization of mammalian oscillators is consistent with the observations
that clock gene rhythms shift phase more rapidly in the SCN than in peripheral oscillators
(Yamazaki et al., 2000), and that peripheral clock oscillations are phase-delayed by 4-12
hours relative to the circadian patterns observed in the SCN (Zylka et al., 1998). The role
of the SCN was also proved by lesion studies. In rats, lesion of the SCN resulted in global
loss of circadian rhythms in physiology and behavior, which indicates that the SCN
generates circadian rhythms (Moore and Eichler, 1972; Stephan and Zucker, 1972). Later
transplantation studies found that SCN tissues could rescue behavioral circadian
rhythmicity (Lehman et al., 1987; Silver et al., 1990).
Detailed molecular dissection of the circadian clock has revealed that the core of
the timekeeping mechanism consists of interlocked transcriptional/translational feedback
loops which are comprised of “negative elements” and “positive elements” whose
interactions are thought to drive overt rhythmicity (Ralph, 1991; Dunlap et al., 1999).
Evidence for the role of these genes as core components of the molecular feedback loop
that regulates mammalian circadian rhythms is based on studies demonstrating that

4

mutation or knockout of these genes in mice alters or abolishes the circadian rhythm of
activity.
Circadian clocks are considered have three parts: input pathways, such as light,
pacemakers, such as suprachiasmatic nuclei (SCN) in mammals, and output pathways,
such as daily activity/sleep rhythms (Eskin, 1979). Figure 1 gives a visual of these
pathways.

Figure 1.1

Circadian timing system.

The circadian rhythm contains three parts: an input pathway, a pacemaker
(suprachiasmatic nucleus), and an output pathway. The input pathway transports
environmental information into the pacemaker, the pacemaker generates oscillations, and
the output pathway translates the oscillations into physiology and behavior.

1.2.1

Input pathway

The input pathway transports environmental information into the pacemaker. The
input information contains light, temperature, food, and osmotic balance. For example,
the SCN receives light input from melanopsin-expressing intrinsically photoreceptive
5

retinal ganglion cells through the retinohypothalamic tract (RHT) (Figure 2) (Hattar et al.,
2002; Do and Yau, 2010).
1.2.2

Suprachiasmatic nucleus
The suprachiasmatic nucleus (SCN) is the pacemaker of the circadian timing

system in mammals. The SCN is a paired neuronal structure located in the anteroventral
hypothalamus, on either side of the third ventricle, and above the optic chiasm (Klein et
al., 1991). The SCN contains about 20,000 neurons: a ventral “core” region which abuts
the optic chiasm and receives retinal input and a dorsal “shell” region which partially
envelops and receives input from the core (Abrahamson and Moore, 2001). The
pacemaker location of mammals was identified by ablation and transplant studies
(Stephan and Zucker, 1972; Ralph et al., 1990).

Figure 1.2

The location of suprachiasmatic nucleus in brain.
6

In addition to neurons, the SCN also contains glial cells which potentially
contribute to pacemaker function. In 2005, Prolo et al found some clock gene expression
in glial astrocytes, and further studies found remarkable circadian variations in glial
morphology in the SCN by immunolabeling of glial fibrillary acidic protein (Lavialle and
Servière, 1993). Moreover, glial signaling can affect neuronal function in other brain
areas (Nedergaard, 1994; Fellin and Carmignoto, 2004; Pascual, 2005).
The mammalian SCN was initially identified as a circadian neural pacemaker in
studies demonstrating that ablation of this structure eliminates circadian patterns of
behavioral activity, endocrine output, and many biochemical processes throughout the
body (Turek, 1985). However, conclusive evidence for the circadian pacemaker function
of the SCN is derived from observations of transplantation studies using donors and hosts
with different circadian genotypes. These observations provide unequivocal
demonstration that a specific circadian property, namely period, can be conveyed by SCN
grafts. They also show that restored rhythms are generated by pacemaker cells in the graft
instead of by surviving SCN cells in cellular metabolism, neuropeptide secretion,
electrical activity, and gene expression, which are endogenous to the SCN in vivo and
persist following isolation of SCN cells in vivo (Klein et al., 1991).
Importantly, these molecular and physiological oscillations are not only an
ensemble property of the entire nucleus but are also generated by individual SCN
neurons, suggesting that the SCN contains a network of cell-autonomous oscillators
(Welsh et al., 1995). In similar fashion, SCN cells in brain slice preparations also exhibit
ensemble rhythmicity in Per-1-driven GFP-fluorescence, and this rhythmic behavior is
derived from the autonomous oscillations of individual neurons with multi-phasic
7

waveforms (Quintero, 2003). Identification of the processes responsible for the relative
coordination of rhythmicity across multiple cellular clocks is of critical importance for
understanding the mechanisms by which individual SCN clock cells are coupled and
function as a pacemaker that regulates circadian rhythms in other cells and tissues.
SCN cells possess both oscillatory and pacemaker properties and, importantly,
these cells are distinguished by the capacity to confer rhythmicity both to rodents with
SCN lesions in vivo and to other cells in vitro. In a number of studies, transplantation of
fetal hypothalamic tissue containing the SCN into arrhythmic hosts with SCN lesions has
been shown to restore circadian behavioral rhythmicity (Ralph et al., 1990; Ralph and
Lehman, 1991). SCN2.2 cells are capable of generating self-sustained rhythms of gene
expression and glucose metabolism intrinsically, of imposing these oscillations on cocultured fibroblasts, and of restoring behavioral rhythmicity when transplanted into hosts
with SCN lesions (Earnest et al., 1999a and b).
Even though the SCN is clearly critical for the expression of overt rhythmicity
throughout the organism, the expression of these clock genes and their rhythmic
regulation are not unique to the SCN, but instead are widely distributed in many
peripheral cells and tissues, ranging from the liver to endocrine tissues to the heart and
skeletal muscles (Shearman et al., 1997; Yamazaki S et al., 2001; Zylka et al., 1998). An
equally intriguing observation was that serum shock, forskolin or corticosteroid treatment
of fibroblast cell lines induced similar in vitro rhythms of clock gene expression
(Balsalobre et al., 1998 and 2000).
The endogenous timekeeping function of the SCN is complemented by its role in
mediating the entrainment of mammalian circadian rhythms to light-dark cycles. Photic
8

information is transduced by the retina and conveyed to the SCN via the
retinohypothalamic tract (RHT), a monosynaptic projection from a subpopulation of
retinal ganglion cells that terminate bilaterally within the ventrolateral subdivision of the
nucleus (Johnson, 1988). Thus, the SCN represents a tissue that comprises all features of
the biological clock: a specialized input pathway, and circadian oscillators with
pacemaker properties capable of driving and/or entraining downstream rhythms (Figure
3).

Figure 1.3

Organization of the circadian clock system.

The SCN receives light information by a direct retinohypothalamic tract (RHT) to entrain
the clock to the 24-hour day. The entrained SCN, in turn, coordinates the timing of slave
oscillators in other brain areas and in peripheral organs.

In the mammalian circadian system, cell-autonomous clocks in the
suprachiasmatic nuclei (SCN) are distinguished from those in other brain regions and
peripheral tissues by the capacity to generate coordinated rhythms and drive oscillations
in other cells. Our understanding of SCN function has changed considerably based on
9

evidence indicating that many peripheral tissues in vivo and fibroblast cell lines in vitro
also express oscillations in molecular components of the canonical clockworks. Yet,
despite these oscillatory properties, peripheral tissues and fibroblast cell lines cannot
function as pacemakers by regulating circadian rhythms in other cells or downstream
processes. Only oscillators derived from the SCN possess the capability to restore
behavioral rhythmicity when transplanted into hosts with SCN lesions and to coordinate
molecular and physiological oscillations in co-cultured cells. The pacemaker function of
SCN oscillators is presumably derived from the distinctive nature of their outputs that
mediate cellular communication between cell-autonomous clocks within the SCN and
from the SCN to downstream oscillators. Diffusible factors constitute at least some of the
SCN-specific signals responsible for its pacemaker function in vivo and in vitro.
Therefore, identification of these diffusible factors will be critical both in elucidating how
SCN circadian outputs coordinate oscillations in downstream tissues and cells, and in
determining what cellular processes distinguish the function of SCN oscillators as a
circadian pacemaker.
1.2.3

Output pathway
Immortalized rat SCN cells (SCN2.2) retain the endogenous oscillatory and

pacemaker properties of the SCN in situ (Earnest et al., 1999a). The development of a coculture model has been instrumental in distinguishing the circadian pacemaker properties
of SCN2.2 cells from the oscillatory behavior of fibroblasts as shown in Figures 2, 3, and
4 (Allen et al., 2001 and 2004; Farnell et al., 2011). Immortalized SCN2.2 cells release
some paracrine signal(s) responsible for the circadian regulation of metabolism in
downstream cells. In this model, SCN2.2 cells are co-cultured with NIH3T3 fibroblasts
10

on cell impermeable inserts (pore size = 1um). Consistent with SCN function in vivo,
SCN2.2 cells endogenously generate circadian rhythms of 2-deoxyglucose (2-DG) uptake
and Per gene expression and conferred this metabolic and molecular rhythmicity to cocultured NIH3T3 fibroblasts as shown in Figure 1.4 (Allen et al., 2001).

Figure 1.4

Schematic illustration summarizing the results of co-culture studies.

SCN2.2-NIH/3T3 fibroblasts co-cultures (top). Serum-shocked (SS) NIH/3T3-untreated
NIH/3T3 co-cultures (bottom). In each culture type, the top (solid) waveform represents
the temporal pattern of metabolic activity (2-DG uptake) and the bottom (dashed)
waveform denotes the profiles of clock gene expression (Per1 and Per2). The thick
arrows between culture types indicate the presence or absence of signals that
communicate rhythmicity to co-cultured cells.
Immortalized SCN cells (SCN2.2) confer metabolic and molecular rhythmicity to
co-cultured NIH/3T3 fibroblasts via some diffusible signal(s) (Allen et al., 2001 and
2004; Farnell et al., 2011). The identity of these signals is unknown. However, circadian
profiling of the SCN2.2 transcriptome indicates that specific signals involved in cellular
11

communication are rhythmically regulated in these cells and thus may provide important
diffusible factors in SCN2.2 coordination of oscillations in co-cultured cells.
At present, limited information is available on what specific output signals are
necessary for SCN pacemaker coordination of circadian rhythmicity in other tissues or
cells. Prokineticin, transforming growth factor-α, and cardiotrophin-like cytokine
represent SCN pacemaker outputs that appear to play some role in at least the circadian
regulation of behavior (Cheng et al., 2002; Kraves and Weitz, 2006; Li et al., 2012).
However, it seems unlikely that these outputs are solely responsible for the entire
spectrum of circadian processes that are synchronized by the SCN pacemaker. Thus, we
believe the proteomic study on the secretome of SCN 2.2 cells will identify SCN output
coordinate oscillations in downstream cells.
1.2.4

Several clock genes in circadian clock system
Several gens such as Clock, Bmal1, Period1, Period 2, Cryptochrome1, and

Cryptochromel 2 have been reported as the core components of mammalian circadian
clock system that make up an auto-regulatory feedback loop. The activation and
repression of the feedback loop take about 24 hours. The proteins produced by these
genes interact with each other in an intricate manner generating oscillations of gene
expression. In Figure 1.5, Bmal1 (brain and muscle ARNT-like protein 1) and Clock
(Npas2 in neuronal tissue), which are heterodimers, from the cytoplasm enter the nucleus
and bind to E-box sequences in the promoters of Period (Per1, 2) and Cryptochrome (Cry
1, 2) genes contributing to the activation of their expression. In the cytoplasm, Period and
Cryptochromel proteins interact with each other by various combinations, the various
combinations enter the nucleus and inhibit the action of Bmal1/Clock or Bmal1/Npas2
12

complexes. Without these complexes activating transcription of the Period and
Cryptochromel genes, Period and Cryptochromel transcripts and their respective protein
products will be declined. Therefore, Period and Cryptochromel genes will shut off their
own transcriptions (Ko and Takahashi, 2006).

Figure 1.5

Circadian clock genes.

Bmal1 (brain and muscle ARNT-like protein 1) and Clock (Npas2 in neuronal tissue),
which are heterodimers, from the cytoplasm enter the nucleus and bind to E-box
sequences in the promoters of Period (Per1, 2) and Cryptochrome (Cry 1, 2) genes
contributing to the activation of their expression. In the cytoplasm various combinations
of Per and Cry proteins interact with each other, enter the nucleus and inhibit the activity
of Bmal1/Clock or Bmal1/Npas2 complexes. Without these complexes activating
transcription of the Per and Cry genes, levels of Per and Cry transcripts and their
respective protein products decline; hence Per and Cry genes shut off their own
transcription (Ko and Takahashi, 2006).
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1.3

Extracellular vesicles
Extracellular vesicles (EVs) were reported late because they are very small

vesicles. At the beginning, scientists thought EVs were a kind of waste secreted out of
cells (Wolf, 1976). With much research, EVs were related to procoagulant particles in
normal plasma (Chargaff, 1946; Dvorak et al., 1981). From 1970 to the 1980s, EVs were
observed in a variety of cell types and biological fluids, such as rectal adenoma
microvillus cells (De Broe, Wieme and Roels, 1975), bovine serum (Benz and Moses,
1974; Dalton, 1975) and seminal plasma (Ronquist et al., 1978). In 1982, Stegmayr and
Ronquist named EVs as prostasomes, and later in 1996, Raposa et al. reported that the
vesicles isolated from Epstein-Barr virus transformed B lymphocytes were exosomes. In
1983, detailed ultrastructural studies showed that vesicles are also released by multivesicular bodies (MVBs) fusing with the cell membrane during the differentiation of
immature red blood cells (Harding, Heuser and Stahl, 1984; Pan and Johnstone, 1983;
Johnstone et al., 1987). It was not until 2006 that EVs were first related to cell-to-cell
communication with the discovery that EVs contain RNA (Valadi et al., 2007; Ratajczak
et al., 2006).
Many researchers have indicated that EVs have different sizes and membrane
composition when secreted from different cellular sources, states, and environmental
conditions. The terminology of these extracellular vesicles is often confounding as many
reports mix these microvesicles together. To clarify nomenclature, many researchers
discriminate these extracellular vesicles by biochemistry and functionality. At present, 3
main subgroups of EVs have been defined (Gould and Raposo, 2013): apoptotic bodies
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released by cell death, microvesicles (ectosomes) released by budding from plasma
membrane, and exosomes released by exocytic fusion of MVBs.
1.3.1

Apoptotic bodies
Apoptotic bodies are released by apoptotic or dying cells at the late stages through

blebbing of the plasma membrane (Beyer and Pisetsky, 2010). The size of the apoptotic
bodies is from 50 to 500nm in diameter. Apoptotic bodies are heterogeneous in shape.
1.3.2

Microvesicles
Microvesicles are membranous vesicles larger than 100nm in diameter that are

pinched directly off the plasma membrane by a variety of cell types (Hess et al. 1999; AlNedawi et al. 2008). Microvesicles are formed by blebbing of plasma membrane during
which fission the plasma membrane stalk detaches the cytoplasmic protrusions (Cocucci
et al., 2009). Microvesicles contain components of membrane lipid rafts such as flotilin1, lineage markers such as platelet/endothelial cell adhesion molecule (Piccin et al.,
2007), and oncogenic growth factor receptors such as EGFRvIII and CD142 (Al-Nedawi
et al., 2008). Microvesicles also contain some specific proteins such as CD35,
glycophorin A (Sadallah et al., 2008), or CD86 and CD47 (Kim et al., 2011).
1.3.3

Exosomes
Exosomes are nanovesicles (30-150nm in diameter) that are homogeneous in

shape. Exosomes were first described in 1983 by Johnstone and coworkers. Exosomes are
intraluminal vesicles (ILVs) contained in MVBs, which are released to the extracellular
environment upon fusion of MVBs with the plasma membrane. The biogenesis and
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secretion of EVs has recently been extensively reviewed elsewhere (Colombo, Raposo,
and Théry, 2014).
Some specific characteristics have been proposed for these subgroups of EVs in
some instances. However, there is still a lack of widely accepted specific markers to
distinguish these populations (Kalra et al., 2013). This may partly be explained by the
lack of standardization of both isolation procedures and methods for the characterization
of EV subgroups. In addition, isolation procedures typically do not unequivocally purify
specific types of vesicles, but instead yield complex mixtures.
Exosomes have been isolated from animals with many diseases; an example is
Niemann-Pick disease (Strauss et al., 2010).
1.3.4

Definition of exosome
To characterize exosomes and distinguish them from the other extracellular

vesicles, some useful strategies can be used. First, one may utilize exosomes’ unique
biophysical features. Exosomes are the only vesicles secreted by living cells. This can be
compared to microvesicles and apoptotic bodies that are produced by apoptotic cells. In
addition, exosomes are nanovesicles between 30 to 150 nm in diameter, whereas
apoptotic bodies range from 50 to 500nm in diameter, and microvesicles are larger than
100nm. Finally, exosomes have a specific floatation density between 1.19 and 1.21 g/ml
(Carayon et al., 2011). Second, one may consider the special composition of proteins,
RNAs and lipids in exosomes. Exosomes are highly enriched in tetraspanins (which are
kind of transmembrane protein) such as CD9, CD63, CD81 (Kleijmeer et al., 1998).
Exosomes are also enriched in heat-shock proteins such as HSP70 and HSP90, which
make exosomes distinct form microvesicles. Furthermore, exosomes contain mRNAs
16

and miRNAs that can be used to control the expression of proteins. In addition,
exosomes involve some specific lipids that are different from microvesicles and apoptic
bodies such as monoacylglycero phosphate (Gallala and Sandhoff, 2011), which is a
specific endosomal polyglycerophospholipid important in exosomes’ biogenesis and not
present in the plasma membrane. Third, one may distinguish exosomes from other EVs
by their different biogenesis pathway. Exosomes are secreted by fusion of MVBs with
the plasma membrane and are therefore vesicles of MVB origin. As such, they express
some classical MVB markers such as ESCRT components TSG101, VPS, and LAMP1.
Lastly, the extracellular domains of their transmembrane proteins are oriented toward the
extracellular environment. Whilst some non-exosomal vesicles may share some of these
properties, these together are the overall features that best summarize exosomes. That
being said, it is perhaps most important to emphasize that exosomes are released from
viable cells.
1.4

Exosome
Exosomes are nanoscale vesicles of 30-150 nm in diameter that are released by a

variety of cell types such as reticulocytes, antigen presenting cells, neoplastic cells, and
neurons (Faure, Lachenal et al., 2006; Kramer-Albers, Bretz et al., 2007; Skog,
Wurdinger et al., 2008). They are detected in biological fluids such as urine (Pisitkun et
al., 2004; Gonzales et al., 2009; Hoorn et al., 2005), ocular fluids (Perkumas et al., 2007),
semen (Poliakov et al., 2009), amniotic fluid (Asea et al., 2008), saliva (Ogawa et al.,
2008), and breast milk (Admyre et al., 2007). In 1987, the term “exosome” was first used
to describe small membrane vesicles formed by vesiculation of intracellular endosomes
and released by exocytosis (Johnstone et al., 1987). In 1987, Johnstone and coworkers
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first named the small membrane vesicles formed “exosomes.” Functionally speaking,
there are three normal techniques to isolate exosomes: 1) differential centrifugation, 2)
immuno-magnetic isolation, and 3) sucrose density gradient. These isolated exosomes
are stable for 90 days at 4ºC (Kalra et al., 2013). Exosomes have some exosomal markers
such as TSG101, CD63, CD9, CD81, and HSP70 that can be identified by assays.
However, different cell type derived exosomes have different exosomal markers.
Exosomes are cargos of proteins, small RNA, and lipids. The different proteins,
smallRNA, and lipids that exosomes contain come from different cell types, times, and
conditions. Another important function of exosomes is cell-to-cell communication. In the
uptake experiment, exosomes can fuse with target cells, revealing that they are indeed
biologically active. With research, exosomes can be used in target drug delivery and
biomarkers of disease (Kalra et al., 2013).
1.4.1

Formation of exosome
To learn more about the functions of exosomes, exosome formation must be

clarified. Exosomes are membrane vesicles that contain a variety of proteins,
microRNAs, and lipids. The sources of the different proteins and lipids are important
cues to figure out the process of exosome formation. Most exosomal proteins are found in
cytosol, the membrane of endocytic compartments, or the plasma membrane. However,
none of the proteins come from nuclear, mitochondrial, endoplasmic reticulum, or golgi
origin. Some studies have revealed that some exosomal proteins are only present at the
cell surface such as CD9, and some exosomal cytosolic proteins play important roles in
the endocytic pathway such as annexin II (Gruenberg and Maxfield, 1995) and the tumorsusceptibility protein TSG101, which has been recently shown to be important for the
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transport of membrane proteins in the endocytic pathway (Babst et al., 2000). Lipid
composition of exosome also indicates how exosomes are formed. The cholesterol
content and fusogenic lipids are related to the secretion of exosomes. In addition,
phosphatidic acid, diglycerides, and ceramides, which are the lipid second messengers,
are also involved in exosome formation (Record et al., 2013). Phosphatidylserine is also
needed by certain proteins to generate exosomes. Therefore, the current hypothesis is
that exosomes are released by exocytosis of multivesicular endosomes.
It is important for eukaryotic cells to communicate with surrounding cells and
even different and distant tissues. This can be managed via the uptake of nutrients via
receipt of signals such as cytokines or chemokines and via the secretion and uptake of
proteins or lipids. Therefore, cells endocytose macromolecules from the exterior
environment or release them into the extracellular space via exocytosis. One method of
exocytosis is the fusion of multivesicular bodies (MVBs) or multivesicular endosomes
(MVEs) with the plasma membrane to release their cargo. MVBs are built in various cell
types and represent precursors of lytic granules in T lymphocytes, major
histocompatibility complex class II (MHC-II)-compartments in antigen-presenting cells,
melanosomes in melanocytes, and late MVBs (late MVEs) in most nucleated cells (Blott
and Griffiths 2002; Stoorvogel, Kleijmeer et al., 2002; Thery, Zitvogel et al., 2002).
These MVBs originate from endocytic vesicles, which are formed by clathrin-dependent
or clathrin-independent endocytosis and fuse with early endosomes. Rab-proteins mediate
endosomal maturation by orchestrating luminal acidification, changes in protein content,
and cellular localization. When the limiting membrane of late endosomes buds into their
lumen, internal luminal vesicles (ILVs) are built within one vesicle (MVB) (Stoorvogel,
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Strous et al., 1991). ILVs will be delivered to lysosomes for degradation or alternatively
released into the intercellular space as exosomes by direct fusion of MVBs to the plasma
membrane (Gruenberg and Stenmark, 2004; Piper and Katzmann, 2007).
Exosomes are formed in the endocytic tract within multivesicular body (MVB)
compartments. The pre-exosomes contained within these compartments are released into
the extracellular fluid space when the outer membrane of the MVB fuses with the plasma
membrane. However, an additional mechanism for formation and release of exosomes
from T cells (specifically Jurkat) has recently been presented. This mechanism involves
the outward budding of plasma membrane domains enriched in exosomal and endosomal
proteins (Booth et al., 2006). Recently studies of mature neurons revealed that exosomes’
release could be regulated by calcium and glutamatergic activity (Lachenal et al., 2011).
In neurons, MVBs are found mainly in somato-dendritic compartments (Von
Bartheld and Altick, 2011). Fusion of endosomes to the plasma membrane is a
fundamental mechanism of synaptic plasticity that allows insertion of post-synaptic
receptors and thereby reinforces synaptic efficacy (Wang et al., 2008).
Inward budding of endosomal membranes results in the progressive accumulation
of intraluminal vesicles (ILVs) within large multivesicular bodies (MVBs).
Transmembrane proteins are incorporated into the invaginating membrane while the
cytosolic components are engulfed within the ILVs (van Niel et al., 2006). Based on their
biochemical properties, intracellular MVBs can either traffic to lysosomes where they are
subjected to proteosomal degradation or to the plasma membrane (PM) where upon
fusion with the PM they release their contents (ILVs) into the extracellular space; these
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ILVs released into the extracellular space are referred to as “exosomes” (Simpson et al.,
2009).

Figure 1.6

Schematic representation of the release of exosomes into the extracellular
space.

Invaginations of the endosomal membranes result in the forming of endosomes, which is
going to form large multivesicular bodies (MVBs). Based on the biochemical properties
of MVBs, they can either traffic to lysosomes where they are subjected to proteosomal
degradation or, alternatively, to the plasma membrane where upon fusion with the plasma
membrane they release their contents into the extracellular space, which contain
exosomes. (Simpson et al. 2009).
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1.4.2

Composition of exosome
Exosomes are microvesicles released into biological fluids by fusion to the

plasma membrane of multivesicular bodies. Exosomes represent a novel way for
intercellular transfer of proteins and RNAs. As a kind of membrane vesicle, they also
contain lipids. Exosomes from different cell sources contain some cell-specific RNAs,
proteins, and lipids, but they are also composed of some ubiquitous proteins.

Figure 1.7

Composition of exosomes.

Exosomes are typically enriched in certain molecules including targeting/adhesion
molecules, membrane trafficking molecules, cytoskeleton molecules, proteins involved in
MVB formation, chaperones, cytoplasmic enzymes, signal transduction proteins, and
functional mRNA and microRNA populations.
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1.4.2.1

Exosomal protein
The exosome proteins from various cell types and biological fluids have been

extensively analyzed by western blotting, LC/MS (liquid chromatography–mass
spectrometry), two-dimensional electrophoresis (2DE) coupled with mass spectrometry
(MS), immunoelectron microscopy, and fluorescence-activated cell sorting. There are
many studies about proteomic analysis of exosomes from variety cell types and biological
fluids. These studies include cells like mast cells (Valadi et al., 2007), oligodendrocytes
(Krämer‐Albers et al., 2007), microglia (Potolicchio et al., 2005), brain tumor cells
(Graner et al., 2009), and neuroglial cells (Fevrier et al., 2004) and also include bodily
fluids such as urine (Pisitkun et al.,2004; Gonzales et al., 2009), plasma (Looze et al.,
2009), breast milk (Admyre et al., 2007), and saliva (Gonzalez-Begne et al., 2009).
Exosomes are rich in membrane and cytosolic proteins and contain minimal ER,
Golgi, nuclear, and mitochondrial proteins. With a lot of data from numerous studies,
exosomal proteins can be divided into ubiquitous and cell-specific proteins. Ubiquitous
proteins are present in exosomes of most cell types. MVB biogenesis proteins include
Alix, TSG101, and clathrin, and TSG101 is important in the transport of proteins into the
endocytic tract. Cytosolic proteins include Rabs, annexins, and tubulin. Rabs could
regulate exosome docking and membrane fusion (Mears et al., 2004) while annexins play
a role in membrane trafficking and fusion events (Futter and White, 2007). Tetraspanins
include CD9, CD63 (Kleijmeer et al., 1998), and CD81. Heat-shock proteins include
HSP60, HSP70, HSPA5, and HSP90. Metabolic enzymes include GAPDH
(Glyceraldehyde 3-phosphate dehydrogenase), enolase 1, aldolase 1, PKM2, PGK1,
GSTP1, and peroxiredoxins. Ribosomal proteins include RPS3. Transmembrane proteins
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include PIGR, LAMP1, and CD59, and signal transduction proteins include syntenin, 143-3, G proteins, CDC42, stomain, RAC1, mucin 1, and RALA. Adhesion proteins include
integrins, which are related to the organization of large molecular complexes and
membrane subdomains, and also include MFGE8. ATPases such as ATP5B and
ATP1A1. Cytoskeletal proteins include actins, tubulins, cofilin 1, profilin 1, myosin,
keratins, and fibronectin 1. Ubiquitin molecules include ubiquitins B. The functions of
these ubiquitous proteins are potentially related to biogenesis of exosomes or some
unknown common exosome functions. In addition, many proteins, like Alix, TSG101,
tubulin, actin, annexins, CD9, CD63, CD81, HSP 70, and GAPDH, are used as protein
markers in western blotting or immunoelectron microscopy to identify exosomes.
Unique cell-derived exosomes also contain some cell-specific proteins that
present some special functions. Exosomes secreted by colon tumor cell line LIM1215
contain A33, cadherin-17, CEA, and mucin 13. Exosomes from dendritic cells (DCs)
contain CD86, which is an important molecule to co-stimulate with T-cells. Exosomes
from antigen presenting cells contain MHC II (Denzer et al., 2000). In addition, T-cellderived exosomes are enriched with T-cell receptors, B-cell-derived exosomes involve
the intercellular adhesion molecule 1 (ICAM1) and CD54, platelet-derived derived
exosomes contain P-selectin, and enterocyte-derived exosomes contain A33 antigen,
dipeptidylpeptidase IV, and CD26. Similarly, colorectal cancer-derived exosomes
contain a coiled coil domain, which locates proteins to early endosomes (Raiborg et al.,
2001).
Some of these exosome proteomic studies have also helped confirm that
exosomes are not just membrane fragments by showing that they lack some abundant cell
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surface receptors. For example, DC-derived exosomes do not express Fc receptor, and Bcell derived exosomes lack transferrin receptor. Furthermore, some of the exosomal
proteins such as annexin II and TSG101 can be found in the endocytic pathway, further
supporting the endosomal origin of exosomes. TSG101 in particular has specifically been
identified to be important in the transport of proteins into the endocytic tract and has also
been shown to be enriched in exosomes. If one ever needs to research exosomal
proteomics, there are some useful databases online such as Vesiclepedia
(www.microvesicles.org/) (Kalra et al., 2012), EVpedia (www.evpedia.info) (Kim et al.,
2013) and ExoCarta (www.exocarta.org) (Simpson et al., 2013).
1.4.2.2

Exosomal RNA
The presence of messenger RNA (mRNA) and microRNAs (miRNA) in

exosomes was first discovered in mast cells by Valadi et al. (2007). 1,300 mRNA and
120 miRNAs were revealed in mouse and human-derived exosomes, but many of the
RNAs were not present in the cytoplasm of the parent cells. This indicated a specific
selection of these RNA species in exosome formation.
Most studies report that the small RNAs in purified exosomes include mRNA,
miRNA of various size, and low levels of ribosomal 18S and 28S RNA. Exosomes
secreted by mast cells have been reported to contain microRNAs and mRNAs with the
function of modulating the protein expression of receiving cells (Skog et al., 2008; Valadi
et al., 2007). Exosomal miRNA has since been identified in circulating tumor exosomes
from ovarian cancer patients and lung adenocarcinoma patients and isolated using
magnetic beads coated with anti-EpCAM antibody. These studies identified differences
in the miRNA profiles of patients and control samples. The profiles of the cancer patient
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miRNA were also established to be very similar to the tumor tissue profiles. Other
identified sources of exosomal miRNA include circulating placenta-derived exosomes,
human saliva, and EBV-infected B-cell exosomes.
Recently it has been demonstrated that exosomal regulatory miRNAs are
functional in their target cells. Pegtel et al. showed that exosomes derived from EBVinfected cells were able to transfer miRNA to an uninfected cell, and once in the cell the
miRNA were able to repress EBV target genes (2010). The incorporation of miRNAs into
exosomes and their secretion into the extracellular environment is proposed to be
independent of the ESCRT machinery. It appears that the shuttling of specific RNA into
exosomes may play an important role in the functioning of exosomes. mRNA and,
particularly, current miRNA analysis of exosomes may offer additional options for
identifying disease relevant molecules.
MicroRNAs (miRNA) are ~22 nt endogenous, noncoding RNA, which play an
important role in regulatory of messenger RNA transcription in both animals and plants
(Bartel, 2009). miRNAs can bind to the target mRNA by base paring, which provides a
convenient strategy to control the expression of a mRNA and the production of protein.
The same miRNA can regulate different mRNAs’ transcription, and also different
miRNAs can regulate the same mRNA’s transcription. The first identified miRNA is lin4, which known to control the timing of developmental transitions (Lee et al., 1993). For
several years after the discovery of the lin-4, there are many new miRNA were found
from flies, worms, and human (Lagos-Quintana et al., 2001; Lau et al. 2001; Lee and
Ambros, 2001). There are more than 2,000 identified human miRNA that have been
found to affect gene regulation in essential biological pathways (Croce and Calin, 2005).
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The biogenesis of miRNA in mammals has been reported in detail. miRNAs are
managed from primary transcripts into ∼70-nt hairpin precursors (pre-miRNA) (Lee et
al., 2002; Zeng and Cullen, 2003) in the nucleus by Drosha RNase III endonuclease that
cleaves the stem at sites near the primary stem loop (Lee et al., 2003). The pre-miRNA is
then transported to cytoplasm from nucleus by Ran-GTP and Exportin-5 (Yi et al., 2003;
Lund et al., 2004). In the cytoplasm, the pre-miRNA is cleaved by another enzyme Dicer,
which is also an RNase III endonuclease (Kim, 2005; Lee et al., 2003). The ~22-nt
fragments are the functional (Kim, 2005). miRNAs come from the intracellular origin,
they can be secreted either by extracellularly bound to lipoproteins (Arroyo et al., 2011)
or cell-derived exosomes as a method of cell-to-cell communication (Valadi et al., 2007).
With the different secreted pathways, miRNA can be detected in cells, exosomes
(isolated from conditioned media), and also EDCM. Compared to the miRNAs bound to
lipoproteins, the miRNAs secreted by exosomes are more stable, because they are
protected by exosome bilayer membrane (Cheng et al., 2014). Mature mammalian
miRNAs bind to their specific target sequences on the 3’-untranslated region (3’-UTR) of
mRNAs by imperfect base pairing, leading to mRNA cleavage or translational repression
(Yekta, Shih, and Bartel, 2004; Kloosterman and Plasterk, 2006). Because one miRNA
may have hundreds of target mRNAs, each miRNA has wide-reaching effects on gene
expression, and together with their target mRNAs they form non-linear gene regulatory
networks.
miRNAs have various functions, including regulation of neuronal development
and differentiation, synapse formation precursorand plasticity (Kloosterman, and
Plasterk, 2006; Fiore and Schratt, 2007; Presutti et al., 2006). miRNA expression levels
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seem to be dynamic while they are altered by environmental stimuli (Rinaldi et al., 2010).
Therefore, miRNAs have been investigated a lot in several diseases, including
Alzheimer's disease (Lukiw et al., 2007), Parkinson's disease (Kim et al., 2007),
schizophrenia (Perkins, 2007), and aggressive behavior (Jensen et al., 2009). miRNAs are
considered as biomarkers in a variety of diseases, such as cancer, heart disease, infection.
In mammals, the suprachiasmatic nuclei (SCN) of the hypothalamus is the
pacemaker of circadian clock, which allows organisms to adapt their physiological and
behavioral process to a cycle about 24 hours (Reppert and Weaver, 2001). CLOCK,
BMAL1, period (per1 and per2), and cryptochrome (cry1 and cry2) are circadian clock
genes that drive rhythmic expression of critical clock components. miRNA is regulatory
small molecule of gene expression, thus, miRNA represent a novel way to regulate
biological timing system.
With the advances in next-generation deep sequencing (NGS), both the known
and novel miRNA can be profiled with minimal RNA input (Cheng et al., 2014).
Therefore, the analysis of microRNA from exosomes and EDCM are easier than before.
Exosomes are isolated from SCN2.2 cells’ conditioned media, which is SCN2.2 cultured
media, with differential ultracentrifugation combined with filtration. With NGS, we set
out to profile miRNA samples from SCN2.2 cells, SCN2.2 cell-derived exosomes, and
SCN2.2 conditioned media.
miRNAs have various functions, including regulation of neuronal development
and differentiation as well as synapse formation precursor and plasticity (Kloosterman
and Plasterk, 2006; Fiore and Schratt, 2007; Presutti et al., 2006). miRNA expression
levels seem to be dynamic while they are altered by environmental stimuli (Rinaldi et al.,
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2010). Therefore, miRNAs have been investigated in several pathophysiological states
including Alzheimer's disease (Lukiw et al., 2007), Parkinson's disease (Kim et al.,
2007), schizophrenia (Perkins, 2007), and aggressive behavior (Jensen et al., 2009).
miRNAs are also considered as biomarkers in a variety of diseases, such as cancer, heart
disease, infection.
1.4.2.3

Exosomal lipid
Exosomes are bilayer membrane nanovesicles, and lipids are the basic materials

used to build lipid rafts and to form membranes with proteins and sugars. However,
compared to the research on protein and RNA profiling, there is limited data available for
exosome lipid composition, even though it is characteristic of cell origin and plays a vital
role in exosome biogenesis (Chu et al., 2005). Lipid composition analysis has been
performed with exosomes derived from dendritic cells (Laulagnier et al., 2004), mast
cells (Laulagnier et al., 2004), reticulocytes (Johnstone et al., 1987; Vidal et al., 1989), B
cells (Denzer et al., 2000; Wubbolts et al., 2003), and platelets (Heijnen et al., 1999).
Exosomes are enriched in sphingomyelin, phosphatidylserine (PS), cholesterol, and
saturated fatty acids when compared to the total cell membrane (Laulagnier et al., 2004;
Llorente et al., 2013; Trajkovic et al., 2008; Wubbolts et al., 2003). Some studies show
that sphingomyelin, phosphatidylcholine and phosphatidylethanolamine that are enriched
in exosomes are inherited from parental cells (Laulagnier et al., 2004; Subra et al., 2010;
Llorente et al., 2013). The first described exosomes come from reticulocytes and have
been analyzed in detail, and studies found they are similar to the plasma membrane of the
producing cell (Johnstone et al., 1987). B-cell-derived exosomes contain lyso-bisphosphatidic acid, which is enriched in late endocytic compartments (Denzer et al.,
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2000). Platelet-derived exosomes contain low levels of phosphatidylserine (PS), which is
present normally at the cytosolic side of the plasma membrane (Heijnen et al., 1999). The
lipid composition of exosomes from other cell types is not known yet, but overall,
compared to parental cells, exosomal lipid content is enriched in sphingomyelin,
phosphatidylserine, phosphatidic acids, cholesterol, bismonoacylglycerophosphate, and
ceramides, and some exosomal lipids are lower such as phosphatidylcholine (Record et
al., 2013). These studies analyzing the lipid composition of exosomes reveal that this
population of vesicles may secrete from a sub-cellular compartment.
Lipid composition of exosomes represents a variety of functions. Some lipids are
related to the formulation of exosomes. For example, cholesterol content of the parental
cells is related to the process of movement of the MVB along microtubules, and
fusogenic lipids are required to allow fusion of the MVB with the plasma membrane and
secretion of exosomes. Some exosome lipids have positive effect on health; for example,
dendritic cell-derived exosomes enriched in fatty acid docosahexaenoic and lysophosphatidylcholine can enhance DC antigenic capacity. In contrast, there are also some
lipids that have negative health effects such as cancer cell-derived exosomes enriched in
prostaglandin PGE2, which play an important role in tumor immune evasion and are
positive for tumor growth. In addition, phosphatidylserine is related to formation of
aggregated exosomes with the calcium present in biological fluids (Fitzner et al., 2011).
1.4.3

Function of exosome
Exosomes were first considered as extracellular vesicles containing cells’

unwanted materials (Vidal et al., 1997) and were thought to be a means of ridding the cell
of unwanted membrane proteins, such as transferrin receptor from maturing red blood
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cells. Now they are widely accepted as a novel mechanism of cell to cell communication
by direct transfer of proteins, microRNAs, and lipids (Raposo and Stoorvogel, 2013). In
fact, exosomes are now thought to have a multitude of roles in normal physiology and
assorted pathological scenarios. Mechanisms underlying these functions are varied and
complex and include combinations of ligands capable of binding different cell surface
receptors on the target cell stimulating a response. Furthermore, exosomes may be taken
up by target cells transferring exosome surface molecules, cytosolic contents and/or
RNA. Unfortunately, little is truly known about the biological function of exosomes.
Some in vivo work performed suggests some specific roles for exosomes, but the vast
majority of studies have concentrated on the possible effects of exosomes on immune
function. There are too many to discuss in the context of this thesis; nevertheless, Thery
et al. (2009) offers an excellent review of proposed functions of exosomes with respect
the immune system.
Cell-to-cell communication can coordinate cell functions, which is significant for
the development and adaptation of multicellular organisms. There are many different
pathway of cell-to cell communication: Recently, exosomes have been considered as a
novel way of cell-to-cell communication by allowing direct transfer of proteins,
microRNAs, and lipids. Protein profiling and nucleic acid profiling have been used to
show that there are many different proteins and microRNAs involved in exosomes.
Furthermore, to investigate the role of exosomes, it should be proven that exosomes
secreted by cells can be taken up by other cells. Some research has reinforced this
evidence. In a recent study, the researcher labelled two kinds of exosomes secreted by
N2a neuroblastoma cells and cortical neurons with GFP-CD63 and GFP-TTC (GFP fused
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with the C-terminal of tetanus toxin). By tracking these two different exosomes, the
researcher found that N2a neuroblastoma cell-derived exosomes could bind to both
neurons and glial cells, and cortical neuron-derived exosomes also could bind and
endocytose into neurons (Chivet et al., 2014). This result showed that exosomes can be
taken up by different cells. Exosomes enter target cells through endocytosis, which has
been investigated by a special recombinant protein, GFP-TTC, which is specifically
endocytosed by neurons. It has also been recently shown that oligodendrocyte-derived
exosomes can enter microglial cells and neurons whether in vivo or in vitro, and they can
modify gene transcription of the latter (Fitzner et al., 2011; Fröhlich et al., 2014; Frühbeis
et al., 2013).
There are three different processes for exosomes to fuse with target cells. The
juxtacrine pathway is used to activate target cells via exosomal membrane proteins that
interact with the target cell. The ectodomain cleavage pathway is another method to bind
target cells via some exosomal membrane proteins that have been cleaved by proteases,
and the fragments can be used as ligands of the target cells (Théry et al., 2001). In
addition, target cells can be fused by non-selective transfer of exosomal proteins or RNAs
(Barry and FitzGerald, 1999).
1.4.4

Methods of isolating exosome
Exosomes are formed by the inward budding of multivesicular bodies (MVBs)

and are released from the cell into the microenvironment following the fusion of MVBs
with the plasma membrane (PM). Purified exosomes are the foundation for the further
biochemical and functional analysis of exosomes. Exosomes are not the only type of
secreted membrane vesicle. Due to the characteristics of exosomes, there are a few
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different methods to isolate them: differential ultracentrifugation, continuous sucrose
gradient, and immune isolation. Because exosomes are present in serum, it is crucial to
avoid contamination with bovine exosomes from the fetal bovine serum (FBS) that is
used to culture the exosome-producing cells (SCN2.2). For this reason, cells are cultured
in medium in which FBS is replaced with B27; alternatively, FBS can be depleted from
endogenous exosomes by overnight high speed ultracentrifugation (Théry et al., 1999;
Blanchard et al., 2002). There are some reports of alternative methods such as free-flow
electrophoresis and column chromatography nevertheless these methods are not widely
used in the field.
1.4.4.1

Differential ultracentrifugation
Differential ultracentrifugation is widely used to isolate exosome form various

cell lines and body fluids (Simpson et al., 2008). Differential ultracentrifugation involves
several steps of centrifugation. The first two steps, which is at 2,000 x g, for 20 minutes,
at 4ºC, and at 10,000 x g, for 30 minutes, at 4ºC, are used to remove cells and some small
debris. After removing the cells and debris, 0.22µm filters are used to purify the
exosomes from larger extracellular vesicles such as apoptosis and microvesicles.
Following the filtration, the ultracentrifugation, which is at 100,000 x g, for 2 hours, at
4ºC, is performed to get the exosome pellet. The exosome pellets are washed with PBS,
and ultracentrifugation again. Such a procedure, however, does not discriminate between
exosomes and other small vesicular structures or large protein aggregates. Therefore,
other criteria must be used to identify exosomes.
This method may result in more protein aggregates and other smaller cellular
debris (including other vesicles) contaminating the final exosome fraction. Filtration may
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be used to replace the centrifugation step prior to the 100,000 x g ultracentrifugation. If
such samples are used in any proteomics analysis, it may lead to the identification of
contaminating proteins as well as exosomal proteins. Furthermore, less abundant
exosomal proteins may be missed because they are masked by high abundance
contaminants.
1.4.4.2

Density gradients
A sucrose density gradient, which is a good way to separate exosomes from other

vesicles, is based on the different sizes of lipid vesicles will float on different sucrose
density layers. This method utilizes the physical properties of exosomes to separate them
from other particles. The initial necessity of this method is determining the density of
exosomes. Several researchers show that their density is between 1.12 and 1.19 g/ml
(Raposo et al., 1996; Théry et al., 1999; Van Niel et al., 2001). For this method, the
isolated exosomes will contain some materials such as protein aggregates or nucleosomal
fragments (Théry et al., 2001). This method is very labor-intensive and is therefore not
widely used for functional studies but may prove useful as an analytical tool.
A compromise between the sucrose density gradient and ultracentrifugation
methods utilizes a sucrose cushion along with differential ultracentrifugation. This
method was first utilized by Andre et al. (2002) to isolate exosomes from fluid of
malignant ascites.
1.4.4.3

Immuno-magnetic isolation
An immuno-magnetic process using magnetic beads has been employed to isolate

highly-purified exosomes (Clayton et al., 2001; Koga et al., 2005). For example, HER2
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antibody (Koga et al., 2005), A33 antibody (Ritter et al., 1997; Heath et al., 1997), and
CD63 antibody (Caby et al., 2005) have been used to isolate unique exosomes.
The immuno-magnetic isolation approach can be performed in cell culture media
containing fetal calf serum and high-Mr protein oligomers, which may otherwise
contaminate conventional preparations. By these means, exosomes can be purified free of
contaminating large-Mr proteins and oligomers that co-sediment with exosomes at high
centrifugal force (Mathivanan et al., 2010). Furthermore, exosomes isolated by the
immune-magnetic isolation approach have fewer histones when compared with exosomes
isolated by differential ultracentrifugation.
A magnetic bead immune capture strategy was employed to isolate circulating
epithelial cell adhesion molecule-positive exosomes from the plasma of ovarian cancer
(Taylor and Gercel-Taylor, 2008) and lung cancer (Rabinowits et al., 2009; Kloecker et
al., 2008) patients. These studies revealed that plasma exosome levels were increased in
patients with advanced disease (Rabinowits et al., 2009). These studies suggest that
circulating exosomes in the body may play a role in pathogenesis and cell-cell or organorgan communications by transporting molecules that need to reach distant cell targets
(Caby et al., 2005).
The immuno-magnetic isolation approach does not require ultracentrifugation.
One example utilizes magnetic beads coated with a particular antibody against a known
exosomal membrane protein. For example, when isolating exosomes from antigenpresenting cells an anti-MHC class II antibody may be used. The CM or biological fluid
is incubated with the beads for 24 hours, ensuring bead saturation. The bead exosome
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complexes are the thoroughly washed leaving just the exosome coated beads which can
be subsequently analyzed.
Immunoislation offers some advantage over the ultracentrifugation techniques
because it allows the capture of exosomes from samples, like CM or biological fluids,
which contain many contaminants or substances that may interfere with purification by
ultracentrifugation (such as fetal bovine serum (FBS) in cell culture medium or albumin
and other abundant proteins in plasma). It is also arguably a gentler process that
minimizes damage to vesicles. However, there is one key issue: the decision on which
antibody to use for exosome capture. A single antibody may not be suitable for capturing
all exosomes. Capture antibodies utilized in various studies include anti-CD63, anti-MHC
class II, anti-Her2, essentially selecting a sub-population of vesicles expressing these
molecules. These sub-populations do not always reflect the composition or function of
the entire exosome population. This technique is also not suited to purifying high
numbers of exosomes from samples. Lastly, the effect of immunoisolation on the
functionality of the exosome is not known; therefore, exosomes captured by this method
may not be appropriate for use in functional immunology and other studies. The
exosomes may need to be liberated from the antibody/bead complex and this extra step
may cause damage to the vesicle.
The decision on which exosome purification strategy to use will ultimately be
based on the sample purity required, the quantity of exosomes needed, the complexity of
the sample source, and whether the exosomes need to be functional. Irrespective of the
method of isolation used it is imperative that the sample is characterized and that the true
nature of the sample is known. There is currently no consensus with respect to the criteria
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for exosome purity, which is something that needs to be addressed. Simpson et al. (2009)
support this view, especially with respect to exosome samples to be used in proteomics
studies, but these authors would advocate that this is equally (if not more) important for
exosome functional studies.
1.5

Relationship between exosome and circadian clock
Exosomes have been isolated from many cell types of the neurvous system.

These include cortical neurons (Chivet et al., 2014), microglia (Potolicchio et al., 2005),
oligodendrocytes (Fitzner et al., 2011), and astrocytes (Taylor et al., 2007). However,
there is no current study about exosomes secreted from SCN, which is the circadian
pacemaker. In vivo, nerve cell-derived exosomes may have been found in cerebrospinal
fluid (Vella et al., 2008). In neurons, glutamatergic synaptic activation was the trigger of
exosome release through calcium entering via N-methyl-D-aspartic acid (NMDA)
receptors (Lachenal et al., 2011).
1.6

Hypothesis and Objectives
This study explores valuable information on the identity of output signals that

mediate SCN pacemaker function and their specificity in coordinating oscillations across
different cell or tissue types. Recently microRNA in exosomes secreted by donor cells is
thought to exert its influence only on the cell that produces it, however these powerful
controllers can also travel between cells and tissues altering cells at a distance. Our
hypothesis is that exosomes are released by clock cells and contain specific RNAs and
proteins, and can be taken up by peripheral cells. Immortalized rat SCN cells (SCN2.2)
retains the endogenous oscillatory and pacemaker properties of the SCN in situ.
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SCN2.2 cells in vitro are able to generate self-sustained rhythms of gene expression and
metabolism, to execute these oscillations on co-cultured fibroblasts, and to restore
behavioral rhythmicity when transplanted into SCN-lesioned hosts. The SCN2.2 cells
have served as an excellent in vitro model system for studying molecular mechanisms
that advance our knowledge of what biochemical signals are involved in coordinating
circadian processes in different tissues. The result of the study may ultimately be useful
in the understanding, diagnosis and treatment of disorders in animal and human health
and performance that result from internal desynchronization of body processes.
The hypothesis that exosomes might present a novel way for intercellular
communication in circadian clock system. We anticipate that this project will yield Thus,
the present studies evaluated the hypothesis that exosomes are released by SCN2.2 cells
and contain specific RNAs and proteins. Specifically, experiments were conducted to
characterize SCN2.2 cells-derived exosomes by: 1) first purifying exosomes and
examining exosomes by morphological analysis; 2) determining whether common
exosomal protein markers are present in exosomes and what kind of RNAs are inside; 3)
evaluating if SCN-derived exosomes can be taken up by fibroblast cells; and 4) defining
the protein contents in exosomes secreted from SCN2.2 cells by a proteomic study.
1.6.1

Objective 1: Examining the presence of exosome released by SCN2.2 cells
and characterizing the morphology and biochemical components in
SCN2.2 cell-derived exosomes.
Exosomes have been demonstrated in many central nerve system as a novel way

for intercellular communication. Thus, by identifying exosomes from mammalian
circadian clock cells and exploring the contents of clock cell-released exosomes at the
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biochemical and molecular level will allow us to understand the role of exosomes in
intercellular communication in circadian clock system.
1.6.2

Objective 2: Determining differential expression of miRNAs from
extracellular matrix (in exosomes and exosome-depleted conditioned
media) and intracellular component of SCN2.2 cells
The miRNAs have been attributed to regulate circadian clock function in several

organisms including mouse retina, mouse SCN, Drosophila brain and Arabidopsis.
Extracellular miRNAs in exosomes, exosome-depleted conditioned media (EDCM), and
their parental SCN2.2 cells were studied by high-throughput small sequencing. Analyses
of differentially expressed microRNAs between intracellular and extracellular
components will help us to find out the key regulatory miRNAs that regulate circadian
rhythmicity in peripheral tissues by facilitating cell to cell communication, and should be
of significant interest to the neuroscience community.
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CHAPTER II
MAMMALIAN SUPRACHIASMATIC NUCLEI -DERIVED EXOSOMES:
IDENTIFICATION AND CHARACTERIZATION

2.1

Abstract
Suprachiasmatic nuclei (SCN) is the master circadian pacemaker in mammals. It

generates coordinated rhythms and drives oscillations in other peripheral tissues and
cells. We have identified that the conditioned media (CM) of SCN2.2 cells confer
molecular rhythmicity to co-cultured fibroblasts via some diffusible factors. However, the
mechanism of diffusible factors transfer from the SCN2.2 cells to other cells is not fully
understood. One potential mechanism is through exosomes. Exosomes, secreted by
various cells, are nanometer-sized vesicles that contain distinct subsets of RNAs and
proteins. They play important roles in cell signaling and intercellular communication.
Therefore, studies were conducted to assess and characterize SCN2.2 cells-derived
exosomes. SCN2.2 cells-derived exosomes were isolated using a differential
ultracentrifugation method. The presence of exosomes was confirmed by transmission
electron microscopy (TEM), western blot analysis and Nanoparticle tracking analysis
(NTA). The purified exosomes were positive for three common exosomal markers (CD
63, HSP 70 and TSG 101), and ranged from 55 to 200 nm in diameter. The exosomal
RNA profile, analyzed by a Bioanalyzer, was different to those found in SCN2.2 cells,
and revealed the presence of large amounts of small RNAs. SCN2.2 cells-derived
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exosomes could be delivered to fibroblast cells in vitro, which implies that exosome may
play important roles in circadian oscillation in peripheral cells. The exosomal protein
contents were evaluated by proteomic analysis. A total of 79 proteins in SCN-derived
exosomes were identified by nano-liquid chromatography-tandem mass spectrometry
(LC-MSMS). Among them, 73 proteins were reported in the ExoCarta, a database of
exosomal proteins, from exosomes of various cell types. Eighteen proteins were related to
neuron-derived exosomes. Interestingly, carbamoyl phosphate synthetase 1, which has
been reported previously to have circadian rhythmicity in liver tissue, has been found in
SCN-derived exosomes. Taken together, these studies demonstrated that exosomes,
containing small RNAs, RNAs and proteins, are released from SCN2.2 cells and likely
have a biological role in circadian clock system.
2.2

Introduction
In mammals, the internal biological clock responsible for the generation of

circadian rhythms and their entrainment to light-dark cycles has been localized to a single
structure: the hypothalamic suprachiasmatic nucleus (SCN) (Klein et al., 1991).
Mammalian cell-autonomous clocks in SCN are distinguished from those in other brain
regions and peripheral tissues by the capacity to generate coordinated rhythms and drive
oscillations in other cells (Bell-Pedersen et al., 2005). Destruction of SCN tissues
abolishes or severely alters the expression of overt rhythmicity, and, where possible,
transplantation of these structures or SCN cells restores some of circadian behavioral
rhythmicity to the organism (Rusak and Zucker, 1979; Turek, 1985; Ralph et al., 1990
and 1991). Another important functional property of the SCN is that its cells are capable
of generating self-sustained molecular and physiological oscillations. Circadian rhythms
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in cellular metabolism, neuropeptide secretion, electrical activity, and clock gene
expression are endogenous to the SCN in vivo and persist following isolation of SCN
cells in vitro (Klein et al., 1991). The SCN contains a network of cell-autonomous
oscillators (Welsh et al., 1995). These molecular and physiological oscillations are not
only a collaborative property of the entire SCN nucleus but are also generated by
individual SCN neurons. Even though the SCN is clearly critical for the expression of
overt rhythmicity throughout the organism, the expression of these clock genes and their
rhythmic regulation are not unique to the SCN, but instead are widely distributed in many
peripheral cells and tissues, ranging from the liver to endocrine tissues to the heart and
skeletal muscles (Shearman et al., 1997; Yamazaki S et al., 2001; Zylka et al., 1998). An
equally intriguing observation was that serum shock, forskolin or corticosteroid treatment
of fibroblast cell lines induced similar in vitro rhythms of clock gene expression
(Balsalobre et al., 1998 and 2000). Expression of clock gene oscillates in peripheral
tissues in vivo, however these cells cannot function as pacemakers by regulating
circadian rhythms in other cells or downstream processes. Only oscillators derived from
the SCN possess the capability to restore behavioral rhythmicity when transplanted into
SCN-ablated hosts, and to coordinate molecular and physiological oscillations in cocultured fibroblast cells.
Immortalized rat SCN cells (SCN2.2) retains the endogenous oscillatory and
pacemaker properties of the SCN in situ. SCN2.2 cells in vitro are able to generate selfsustained rhythms of gene expression and metabolism, to execute these oscillations on
co-cultured fibroblasts, and to restore behavioral rhythmicity when transplanted into
SCN-lesioned hosts ( Earnest et al., 1999a,b). The development of a co-culture model has
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been instrumental in distinguishing the circadian pacemaker properties of SCN2.2 cells
from the oscillatory behavior of fibroblasts (Allen et al., 2001 and 2004; Farnell et al.,
2011). Immortalized SCN2.2 cells release some paracrine signal(s) responsible for the
circadian regulation of metabolism in downstream cells. In this model, SCN2.2 cells are
co-cultured with NIH/3T3 fibroblasts on cell-impermeable inserts. Consistent with SCN
function in vivo, SCN2.2 cells endogenously generate circadian rhythms of 2deoxyglucose (2-DG) uptake and Per gene expression and conferred this metabolic and
molecular rhythmicity to co-cultured NIH/3T3 fibroblasts as shown confer metabolic and
molecular rhythmicity to co-cultured NIH/3T3 fibroblasts via some diffusible signal(s)
(Allen et al., 2001 and 2004; Farnell et al., 2011). However, the type of signal that SCN
cells use to coordinate circadian rhythmicity in fibroblast cells is currently unknown.
Circadian profiling of the SCN2.2 transcriptome indicates that specific signals involved
in cellular communication are rhythmically regulated in these cells and thus may provide
important diffusible factors in SCN2.2 coordination of oscillations in co-cultured cells
(Allen et al., 2001).
Exosomes are 30-150 nm membrane vesicles secreted by different types of cells
(Schorey and Bhatnagar, 2008; Vlassov et al., 2012). They are present in body fluids
including saliva, blood, urine, milk, and amniotic fluid. Exosomes contain distinct micro
RNAs and proteins depending upon the tissue and cells from which they are secreted, and
have been implicated in a variety of physiological and pathological conditions (Keller et
al., 2011). The coding RNAs in exosomes can be translated into proteins by recipient
cells and non-coding small exosomal RNAs have been reported to regulate gene
expression in recipient cells (Mittelbrunn et al., 2011; Valadi et al., 2007). These
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exosomes play important biological function in immune response, oxidative stress,
regulation of angiogenesis and apoptosis and intercellular communication (Ailawadi et
al., 2015). Recently, secretion of exosomes by different neuronal cells have been reported
by different studies (Vingtdeux et al., 2007; Putz et al., 2008; Ghidoni et al., 2009;
Lachenal et al., 2010; Chivet et al., 2014). Exosomes have been proposed to participate in
intercellular communication that contributes to the normal physiology of the nervous
system (Lachenal et al., 2010; Chivet et al., 2013). Circulating miRNAs that are
associated with extracellular vesicles may play a role in the regulation of the molecular
clockworks in peripheral circadian oscillators (Shende et al., 2011, 2013, and 2014).
Exosomes have been found to be required for the proper function of the circadian output
in Neurospora (Guo et al., 2009). However there has been no evidence or report that SCN
can secrete exosomes. Thus, the present studies evaluated the hypothesis that exosomes
are released by SCN2.2 cells and contain specific RNAs and proteins. Specifically,
experiments were conducted to characterize SCN2.2 cells-derived exosomes by: 1) first
purifying exosomes and examining exosomes by morphological analysis; 2) determining
whether common exosomal protein markers are present in exosomes and what kind of
RNAs are inside; 3) evaluating if SCN-derived exosomes can be taken up by fibroblast
cells; and 4) defining the protein contents in exosomes secreted from SCN2.2 cells by a
proteomic study.
2.3
2.3.1

Materials and Methods
Cell lines and culture reagents
Rat circadian clock cell line SNC2.2 was obtained from Dr. David Earnest from

Texas A&M Health Science Center (College Station, Texas). SCN2.2 cell line SCN2.2
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cells (passages 15 and 16) were seeded on laminin-coated culture dishes (60 mm;
Corning, Corning, NY) and maintained at 37°C and 5% CO2 in minimum essential
medium (MEM) supplemented with 10% FBS (HyClone laboratories, Inc., UT, USA),
3,000 µg/ml glucose, and 292 µg/ml l-glutamine (all supplemented products were from
Gibco of Thermofisher.com, Carlsbad, CA, USA). At 48-h intervals, the medium will be
changed and cultures will be split at 1:3 or 1:4. Before experimental analysis, cultures
will be plated on multiple flasks (75 cm2) coated with poly-d-lysine and laminin. At 24h
after plating, the culture medium will be changed so as to, respectively, reduce the FBS
concentration to 10% and then to 5%. To facilitate cell cycle and circadian clock
synchronization across cultures, cells were subjected to medium replacement and
exposed to serum-free neurobasal medium (NM) supplemented with 3,000 µg/ml
glucose, 292 µg/ml l-glutamine, and 1× B-27 serum-free supplement. Cultures were
rinsed and thereafter maintained in serum-free neurobasal medium with supplements for
24 hours.
2.3.2

Conditioned media (CM) collection and exosome isolation
Brief overview of the present study is illustrated in Figure 2.1. CM of SCN2.2

cells grown as described above were collected, and immediately centrifuged at 2000 x g
for 20 minutes to remove any cell debris. Supernatant was collected and transferred to
ultracentrifuge polyallomer tubes (Beckman Coulter, Brea, CA, USA). Samples were
then centrifuged again at 10,000 x g for 30 minutes at 4°C, in order to pellet larger
apoptotic bodies and microvesicles. Supernatant was then collected, and transferred to
new ultracentrifuge tubes followed by filtration of 0.22µm filters (EMD Millipore,
Billerica, MA, USA). Exosomes were pelleted by ultracentrifugation at 100,000 x g for 2
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hours at 4°C with a Type 70 Ti rotor (L-50 ultracentrifuge; Beckman Coulter, Brea, CA,
USA). The pelleted exosomes were pooled, washed once in PBS pH 7.3, and were
centrifuged again by 100,000 x g for 1 hour (45Ti rotor, L-50 ultracentrifuge; Beckman
Coulter). Exosomes were resuspended in 100 µL PBS, or in lysis buffer (Total exosome
RNA/Protein extraction kit, Lifetechnolgies, Palo, Alto, USA), depending on the
downstream assays. The re-suspended samples were stored at -80°C, if not immediately
used. After removal of CM for exosome isolation, cells remaining on a dish were
trypsinized at 37 °C for 5 minutes. SCN2.2 cell pellets were snap frozen in liquid N2, and
stored in -80°C.

Figure 2.1

Schematic illustration summarizing the steps of SCN 2.2 cells-derived
exosome isolation by the combination of differential ultracentrifugation and
filtration. EDCM: exosome-depleted CM
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2.3.3

Transmission electron microscopy
Exosomes equivalent to 5 µg of protein content prepared as described above were

pelleted by ultracentrifugation at100, 000 x g (Beckman Coulter) for 2 hours at 4°C.
Pellets were washed with PBS once, resuspended in PBS, and was loaded onto a formvarcarbon coated grid (Ted Pella Inc., Redding, CA, USA). Samples were fixed in 2%
paraformaldehyde and 1% w/v gluteraldehyde, and contrasted in 2% uranyl acetate. The
excess liquid was removed and the grid dried at room temperature then viewed in a JEOL
transmission electron microscope 1230 (JEOL USA, Inc; Peabody, MA, USA).
2.3.4

Nanoparticle tracking analysis (NTS)
Size and concentration of purified exosomes were determined by Nanoparticle

Tracking Analysis (NTA) using NanoSight NS300 (Malvern Instruments Ltd.,
Worcestershire, UK). Data acquisition and analysis was performed using NTA 2.3
Analytical Software. Five video files of 60 s at camera level 10 from each sample were
recorded. Detection threshold limit 10 was used to analyze size and concentration of
vesicles. The concentration of exosomes was divided by the total number of cells to
calculate the production of exosomes (particles) per cell.
2.3.5

Cellular and exosomal total RNA isolation and quantification
Total cellular RNA from SCN 2.2 cells was later extracted from individual

samples using RNeasy Kit protocols (Qiagen, Valencia, CA, USA). DNase I (Qiagen)
treatment was performed on-column according to manufacturer’s instructions, and
samples were stored at -80ºC in nuclease-free water. Exosomal RNA isolation was
performed using the Total Exosome RNA Isolation Kit (Life Technologies, Palo Alto,
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CA), according to the protocol from the manufacturer. The RNA concentration was
determined by spectrophotometry analysis with a NanoDrop 2000 instrument (Thermo
Scientific). Each purified RNA sample was then analyzed using an Agilent
Bioanalyzer on an RNA Nano 6000 Chip according to manufacturer’s instructions
(Agilent Technologies, Santa Clara, CA, USA). This analysis was conducted
concurrently on triplicate aliquots of each sample, and was repeated three times.
2.3.6

Determination of protein concentrations
Isolated exosomes and cells were prepared in RIPA lysis buffer (1 mM NaF,

2 mM Na2VO4, 2 mM leupeptin, 2 mM pepstatin, 2 mM PMSF, and 10 μM MG132)
supplemented with a HALT protease inhibitor cocktail. Protein concentrations were
measured using a BCA protein assay kit (Thermo Scientific Pierce, Rockford, IL, USA).
Twenty-five microliters of BSA standard or 25 μl of sample were transferred to a 96 well
plate followed by addition of 200 μl working reagent (working reagent; 50:1 ratio of
assay reagents A and B). The plate was incubated for 30 minutes at 37°C, before being
analysed with a SpectraMax 384 Plus spectrophotometer at 562 nm and the SoftMax Pro
software (Molecular Devices, Sunnyvale, CA, USA).
2.3.7

Western blot analysis
Aliquots with the same total protein content (10 µg) from exosomes, SCN2.2

cells, and exosomes-depleted CM (EDCM) were loaded and resolved in Novex 4–15%
Tris-glycine gel (Lifetechnogies, Austin, Texas, USA). Gels were then transferred to
PVDF Immobilon membranes (Millipore Billerca, MA, USA). Membranes were
incubated in 5% milk with TBST (10 mM Tris, 0.15 M NaCl, 0.1% Tween-20, pH 7.5 for
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one hour, and then probed with the CD63, HSP70, TSG101, or Golgi-97 primary
antibody (System Biosciences, Palo Alto, CA, USA; Thermo Scientific Lifetechnologies,
Palo Alto, CA, USA) at the 1:1000 dilutions in 1% nonfat dried milk, 0.05% Tween-20
Tris-buffered saline (TBST) for overnight at 4°C. Membrane blots were washed with
TBST for 10 minutes for three time, and then incubated one hour at room temperature
with the appropriate horseradish peroxidase (HRP)-conjugated secondary antibody (1:10
000 dilution; System Biosciences, Palo Alto, CA, USA; Thermo Scientific
Lifetechnologies, Austin, Texas, USA). The immunocomplexes were detected by
chemiluminescence (ECL, GE Healthcare, Pittsburgh, PA, USA). Immunoreactive signal
was generated by enzyme-catalyzed chemiluminescence (Perkin Elmer, Boston, MA,
USA) and detected on film (Biomax; Kodak, Rochester, NY, USA).
2.3.8

Exosomes labeling and uptake analysis of fibroblast cells with labelled SCNderived exosomes
Purified exosomes released from SCN cells were re-suspended in 100 µl of PBS

and then combined with 1 µl of SYTO RNASelect fluorescent stain solution (Molecular
Probes, Eugene, OR, USA) following the manufacturer's instructions. Briefly, exosomes
were incubated at 37°C for 20 min in the dark and then passed through Exosome spin
columns MW 3000 (Invitrogen, Carlsbad, CA, USA) to remove any unincorporated dye
from the labelled exosomes. For the in vitro tracing, the 4-well Chamber Slide System
was prepared, with 104 NIH/3T3 fibroblasts cells/well, and the labelled exosomes were
added to the NIH/3T3 cells. Samples were incubated at 37°C for 3 hours, and fixed with
4% paraformaldehyde at room temperature for 20 min, and then permeabilized with 0.1%
Triton X-100 for 5 minutes. Lastly, NIH/3T3 fibroblast cells were stained with Alexa
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Fluor 594 and mounted in ProLong Gold Antifade Reagent with DAPI (Lifetechnolgies,
Palo, Alto, USA). Images were acquired using the Zeiss LSM510 META Confocal
Imaging System (Zeiss, Peabody, MA, USA).
2.3.9

Proteome profiling using nano-liquid chromatography-tandem mass
spectrometry (LC-MSMS)
Purified exosome pellets from four replicates samples, each with a pool of 25

samples, were resolved in a 6 M urea and 50 mM ammonium bicarbonate. Protein was
reduced by adding 1/10 volume of 50 mM DTT and incubating for one hour at 65oC, and
followed by alkylation with 1/10 volume of 100mM iodoacetamid for 30 min at room
temperature in dark. Trypsin was added up to substrate: trypsin ratio of 50:1. Digestion
was carried out overnight at 37oC. The resulting peptide mixture was acidified with
formic acid (0.1% final concentration), desalted and concentrated with peptide macrotrap cartridge according to manufacturer’s instructions (Michron BioResources, Inc;
Auburn, CA) (Pechanova et al., 2010). Peptides were lyophilized and stored at -80°C.
Immediately before mass spectrometry, the peptides were re-suspended in formic acid
and acetonitrile. LC-MSMS raw data was collected using Ultimate 3000 LC system
(Dionex) and LTQ-Orbitrap Velos mass spectrometer (Thermo Scientific). The spectra
wa searched against a Rattus subset of the National Center for Biotechnology Information
(NCBI) database, using SEQUEST algorithm of Proteome Discoverer software (Thermo
Scientific). The results were filtered by 1% False Discovery Rate (FDR). Identification of
the resulting peptide mass and the associated fragmentation spectra were submitted to
search the non-redundant database of National Center for Biotechnology Information
(NCBInr). Homologous proteins were found via BLASTP searches (BLOSSUM62)
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against NCBInr or UniProtKB databases. Functional classification of differentially
abundant proteins were based on Gene Ontology (GO) annotations. The GO tools were
used to assign protein’s GO terms as a cellular component, biological process, and
molecular function.
2.4
2.4.1

Results
Exosomes are released from SCN2.2 cells
Exosomes were isolated from CM of SCN2.2 cell using a combination of

differential ultracentrifugation and ultrafiltration method (Théry et al., 2006). SCNderived exosomes were morphologically characterized by examining the shape and size
by means of transmission electron microscope. Transmission electron microscopy
showed the purified exosomes approximately 40-100 nm in diameter (Figure 2.2), which
were similar to the size and morphology of exosomes, as described as “typical cupshaped” after fixation, adhesion, negative staining, and visualization by TEM (van der et
al., 2016, review).
NTS analysis of the exosomes was performed to accurately determine the particle
size, distribution and concentrations (Figure 2.3), and revealed that the SCN2.2 cellsderived exosomes were smaller than 300 nm; most are about 95–155 nm in size (Figure
2.3 A). These particles had an average mean size of 140 nm (data not shown) and an
overall mode of about 124 nm (Figure 2.3C), reflecting the expected size of exosomes.
The numbers of exosomes released per cell was calculated to be 1485 particles/cell
(Figure 2.3 B).
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Figure 2.2

The representative photomicrographs illustrating the morphological
properties of exosome by TEM.

Isolated exosomes were fixed and deposited onto formvar/carbon-coated copper grids, as
described in Materials and Methods, and stained with 2% uranyl acetate. Vesicles were
then viewed for TEM using JEOL JEM 1230. TEM revealed vesicles of about 30-150
nm, consistent with sizes of exosomes. Scale bar = 100 nm.
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Figure 2.3

Particle analysis of exosome purified from SCN2.2 cell media.

(A) Yield (particles per cell) and size distribution of SCN2.2-derived exosomes were
analyzed on a NanoSight™ NS300 instrument show all particles to be smaller than 300
nm; most are about 95–155 nm in size. (B) The number of exosomes released per cell.
Resultant concentration of exosomes was divided by the total number of cells to calculate
the production of exosomes per cell. (C) The average mode of exosomes. Experiment
was repeated 7 times with three replicates.

B

C
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2.4.2

SCN2.2 cells-derived exosomes are positive for exosomal protein markers
To obtain further proof that the particles identified from TEM and NTS were

exosomes, we performed the western blot analysis to see if exosomal protein markers
were present. It is highly recommended by the International Society for Extracellular
Vesicles that 3 or more exosomal marker proteins should be characterized in at least a
semi-quantitative manner, such as western blot analysis, in any exosome preparation,
including exosome isolates from secreting cells in vitro (Lötvall et al., 2014). The
proteins characterized are expected to be present in the exosomes of interest, especially
transmembrane proteins (such as CD63, CD9), cytosolic proteins with membrane-binding
capacity (TSG101), and heat shock proteins (HSPs). In addition, the level of presence of
proteins not expected to be enriched in exosomes of endosomal origin should also be
determined, such as Golgi-97. Our western blot analysis revealed that the isolated
exosome from SCN2.2 cells were positive for one for Tetraspanins proteins (CD63),
HSP70, and TSG101 as shown in Figure 2.4, three well-characterized exosomal protein
markers (Lötvall et al., 2014; Théry et al., 2006; van der et al., 2016) . In addition, we
demonstrated the absence of Golgi-97 in purified exosomes. It is also suggested that
exosomes, secreted in vitro by cultured cells, should be compared with those of parental
cells, to determine level of enrichment of the exosomes components. SCN2.2 cells were
only positive for HSP 70, and negative for CD63, TSG101, and Golgi-97 (Figure 2.4).
Additionally, CD63, HSP70, TSG101 and Golgi-97 were not present in EDCM.
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Figure 2.4

Analysis of exosomal markers CD63, HSP70, and TSG101 by western
blots.

Exosomes were purified from CM of SCN2.2 cell by the combination of differential
ultracentrifugation and filtration method. SCN2.2 cells, Exosomes, and EDCM from
three separate cell culture media preparations were subjected to western blot analyses
with antibodies against CD63, HSP70 and TSG101. Standard western blot procedures
with anti-CD63, HSP70, and TSG101 antibodies were used to detect the exosomal
protein
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Figure 2.5

Analysis of RNA contents in exosomes and SCN2.2 cells.

(A) The gel image (from the Agilent Bioanalyzer 2100) for RNA contents derived from
exosomes and SCN2.2 cells. Lanes 2-4 (from left to right) show 18rRNA and small
RNAs in exosomes. Lanes 5-7 show two distinct bands corresponding to the 18S and 28S
ribosomal RNAs in SCN2.2 cells. (B) Electropherogram (from the Agilent Bioanalyzer
2100) for exosomal total RNA and SCN2.2 total RNA run with RNA 6000 Nano Chip.
The 18S and 28S RNA peaks are clearly defined in the bottom of figure B.

2.4.3

Presence of RNAs in exosomes derived from SCN2.2 cells
To evaluate the differences in RNA size distribution profiles of exosomes and

their parental cells, RNA was isolated from each source and analyzed by Bioanalyzer
with RNA 6000 Nano Chip. It was observed that pattern of RNAs inside of exosomes
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were total different from those cellular RNAs in SCN2.2 cells, as shown in Figure 2.5.
Exosomes contained mainly small RNAs of less than 250 nucleotides (nts) with
undetectable 28S ribosomal RNAs. However, 18S ribosomal RNAs were found inside of
exosomes, as reported by Willms et al. (2016). Two major peaks of 28S rRNA and 18S
rRNA were found in SCN 2.2 cells (Figure 2.5).
2.4.4

Uptake of SCN2.2 cells-derived exosomes by NIH/3T3 fibroblasts
Since microRNAs regulate gene expression intracellularly, we investigated

whether RNA containing exosomes released from SCN2.2 cell could be taken up by
NIH/3T3 fibroblast cells. The exosomes were purified from CM of SCN2.2 cells and
labeled with a lipophilic fluorescent dye. The labeled exosomes were incubated with
NIH/3T3 fibroblast cells. As shown in Figure 2.6, binding of the fluorescently labeled
exosomes could be detected 3 hours post-incubation within the cytoplasm of fibroblast
cells, but not nucleus of the cells, suggesting that exosomes can be taken up intracellularly
into the cytoplasm.
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Figure 2.6

Uptake of SCN2.2 cells-derived exosomes in NIH/3T3 fibroblasts in vitro.

Exosomes were isolated from conditioned media of SCN2.2 cells and pre-labeled with
SYTO RNA Select stain. Fluorescently labeled exosomes were added to NIH3T3 cells
and incubated for 3 hours. NIH3T3 cells were then fixed and stained with Alexa Fluor
594 phalloidin and DAPI. Exosomes were stained with SYTO RNA Select stain (RNA,
green); NIH3T3 cells were stained with Alexa Fluor 594 phalloidin (actin, red); Nuclei of
NIH3T3 cells were stained with DAPI (DNA, blue). Scale Bar: 20 µm.
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2.4.5

Protein profiles of exosomes released from SCN2.2 cells
Mass Spectrometry (nano-LC-MS/MS) analysis of isolated exosomes found many

proteins. A total of 79 proteins were identified by nano-LC-MS/MS (Table 2.1). These
included 2 heat shock proteins, 8 proteins that were involved in Adhesion, membrane
transport, and fusion, 16 secreted proteins, 9 cytoskeleton-related proteins, 20 proteins
related to protein synthesis and post-translation modification, 7 proteins which were
implicated in carbohydrate metabolism, 2 chromatin structural proteins,1 ubiquitin
modifier protein, 1 base membrane protein, 2 mRNA splicing protein, 2 RNA binding
proteins, 2 tetraspanins, 2 proteins involved in transcription, 2 protein associate with
proteasome, and 1 lipid binding protein (Table 2.1). About 25% proteins in exosomes are
involved in protein synthesis and post-translation modification, while secreted proteins
consist of 23% of identified proteins (Figure 2.7). Comparison with ExCarta exosome
database, 73 proteins in SCN-derived exosomes were reported in exosomes isolates of
various cell types. Most of SCN-derived exosomal proteins display unique characteristics
with respect to compositions of many functional categories of proteins. However, Acylcoenzyme A thioesterase 12 isoform X1, Hist1h3a isoform X2, Pyruvate kinase PKM
isoform X1, netrin-1 precursor were present in SCN2.2-derived exosomes, however not
found in other exosomes. It is worth noting that netrin-1 precursor has been reported in
the regulation of neuron development (Finci et al., 2015). Eighteen proteins were related
to neuron-derived exosomes (Table 2.2). Interestingly, carbamoyl phosphate synthetase
1, which has been reported previously to have circadian rhythmicity in liver tissue, has
been found in SCN-derived exosomes (Reddy et al., 2006).
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Figure 2.7

The exosomal protein function and their relative abundance.
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Table 2.1

Summary of exosomal proteins in SCN2.2 cells-derived exosomes and their
function

Adhesion, membrane transport, and fusion
Clathrin heavy chain 1
Clathrin light chain A
Transitional endoplasmic reticulum ATPase
Galectin-3-binding protein precursor
Lactadherin isoform 1 precursor
Annexin 2A, A11
Major vault protein
Nucleolin
Secreted proteins
Collagen α-1(I), α-2(I), α-2(V) chain precursor
fibronectin isoform X3
Nuclease-sensitive element-binding protein 1
Serum albumin precursor
Keratin, type I cytoskeletal 10, 14
Keratin, type II cytoskeletal 1, 5, 6A
Keratin, type II cytoskeletal 2 epidermal
Procollagen C-endopeptidase enhancer 1 precursor
Netrin-1 precursor
Anionic trypsin-1 precursor
Biglycan precursor
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Table 2.1 (Continued)
Cytoskeleton-related proteins
Actin, cytoplasmic 2; gamma-enteric smooth muscl
Tubulin β5; Tubulin alpha-1B chain
Beta-actin-like protein 2
Myosin-9
Protein FAM65B
Programmed cell death 6-interacting protein
Syntenin-1
Baculoviral IAP repeat-containing protein 6
Molecular chaperones
HSPA8 (heat shock cognate 71kDa protein)
HSP90AB1(heat shock protein HSP 90-beta
Protein synthesis and post-translational modifications
HIST2H2AB (histone cluster 2, H2ab)
Histone cluster 1, H2bo
60S acidic ribosomal protein P2, P1, L18, P0
40S ribosomal protein SA, S5 isoform 1, S3, S12, S4 X isoform, S15, S17, S3a, S24,
S7, S14, S18
Carbohydrate metabolism
Pyruvate kinase PKM isoform X1
Chromatin structural and regulatory proteins
H2A histone family, member X and V
Glyceraldehyde-3-phosphate dehydrogenase
ATP-citrate synthase isoform 2
Aldehyde dehydrogenase, mitochondrial precursor
Ferritin heavy chain
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Table 2.1 (Continued)
Chromatine structural and regulatory proteins
Core histone macro-H2A.1
Histone H1.4
Ubiquitin modifiers
Guanine nucleotide-binding protein subunit beta-2-like 1
Basement membrane
laminin subunit beta-1 isoform X2
mRNA splicing
small nuclear ribonucleoprotein Sm D1
serine/arginine-rich splicing factor 2
RNA binding
Lupus La protein homolog
Carbamoyl-phosphate synthtase*
Tetraspanins
CD9 antigen
CD81 antigen
Transcription/translation
Elongation factor 2
Eukaryotic translation initiation factor 3 subunit F
Proteasome regulatory particle
26S proteasome non-ATPase regulatory subunit 6
26S proteasome non-ATPase regulatory subunit 2
Lipid Binding
Acyl-coenzyme A thioesterase 12 isoform X1
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Table 2.1 (Continued)
Unknown function
Uncharacterized protein LOC 10091036
Uncharacterized protein Hist1h3a isoform X2

Table 2.2

Eighteen Proteins in SCN-derived exosomes have been reported in other
neuron-released exosomes

Protein Name

ExoCarta
ID

Gene Symbol

Clathrin heavy chain 1

54241

CLTC

Actin, cytoplasmic 2

287876

Actg1

heat shock cognate 71 kDa protein

24468

HSPA8

histone cluster 2, H2ab

621893

Hist2h2ab

tubulin beta-5 chain

29214

Tubb5

lactadherin isoform 1 precursor

25277

Mfge8

H2A histone family, member X

500987

H2AFX

glyceraldehyde-3-phosphate dehydrogenase

24383

GAPDH

procollagen C-endopeptidase enhancer 1 precursor

18542

Pcolce

actin, gamma-enteric smooth muscle

11468

ACTG2

keratin, type II cytoskeletal 1

300250

KRT1

keratin, type II cytoskeletal 5

110308

Krt5

keratin, type II cytoskeletal 6A

16687

Krt6a

heat shock protein HSP 90-beta

301252

Hsp90ab1

histone H1.4

50709

Hist1h1e

beta-actin-like protein 2

345651

Actbl2

programmed cell death 6-interacting protein

501083

PDCD6IP

eukaryotic translation initiation factor 3 subunit F

66085

EIF3F
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Discussion
Our results support the hypothesis that exosomes are released by SCN2.2 cells

and contain specific RNAs and proteins. We used biochemical and morphological
approaches, such as transmission electron microscopy, nanoparticle tracking analysis, and
the presence of exosomal protein markers CD63, HSP70, and TSG101 in the isolated
exosomes which support the conclusion that exosomes are present in the conditioned
media of SCN2.2 cells. The tetraspanins CD63, along with heat shock proteins HSP70
and HSP90 are typical exosomal marker proteins (Théry et al., 2006; Lötvall et al., 2014).
Nanoparticle tracking analysis was used to quantify and determine the size of exosomes
released by SCN2.2 cells, which had the mean size of the most abundant vesicles (about
124 nm) corresponded to exosomes (Tomlinson et al., 2015). Given that exosomes are
typically 30–150 nm in diameter, it is likely that isolated particles from SCN2.2 cells
were exosomes.
Research into exosomal signaling in the central nerve system is limited especially
with regard to mammalian circadian clock tissues or cells. However, the exosomes
released from several other neuronal cells in vitro have been implicated in the regulation
of synaptic function (Faure et al., 2006), neuron-to-astrocyte signaling (Morel et al.,
2013), neurodevelopment (Liu et al., 2015), and neuroimmune function (Cossetti et al.,
2014). Exosomes have been shown to be released in vitro by a wide variety of cell types
in neuron system such as primary cortical neurons, neuroglial cell, Schwann cells (Faure
et al., 2006; Fevrier et al., 2004; Lachenal et al., 2011 and 2013; Lopez-Verrilli et al.,
2012; Pegtel et al., 2014). Here, we have purified and identified the exosomes from the
extracellular matrix of rat SCN2.2 cell. The SCN-derived exosomes match in
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morphology, size, and protein contents from the other cell types (Faure et al., 2006;
Chivet et al., 2013; Potolicchio et al., 2005; Rajendran et al., 2014; Lötvall et al., 2014).
We have found a cluster of small RNA species in the exosomes; in contrast to
SCN2.2 cellular RNAs which display profiles representative of eukaryotic cells with
majorities of 18S and 28S rRNAs and comparatively low percentages of transcripts
below 200 base pairs. In addition, the presence of 18rRNA in SCN2.2-derived exosomes
was observed. According to the previous published literatures, it seems that 18S rRNAs
are absent from exosomes (reviewed in Lötvall et al., 2014). Majorities of the exosomal
RNAs are microRNAs, transfer RNA, lncRNA, piwi-interacting RNA, small nuclear
RNA, and small nucleolar RNA (Bellingham et al., 2012; Lötvall et al., 2014; Nolte-'t
Hoen et al., 2012).

However, 18S rRNAs have been found in other cells-derived

exosomes (Balaj et al., 2011; Hong et al., 2009; Pedersen et al., 2015; Willms et al.
2016). It has been suggested that RNA species may differ in exosomes released from
different cells, where exosomes with a diameter larger than 100nm seem to contain a
greater fraction of rRNA (Lässer et al., 2013).
Exosomes secreted by SCN2.2 cells contain microRNAs, as demonstrated in
Bioanalyzer analyses. Given that single miRNAs have multiple targets and many
miRNAs can target the same mRNA, the impact of exosome-mediated local transfer of
miRNA from donor cells on the post-transcription regulation in recipient cells may be
quite extensive (Cocucci and Meldolesi, 2015). The task of neuronal exosomes is not just
restricted to secretion of functionally microRNA and proteins but also to their ability to
communicate with other cells in the brain (Chivet et al., 2013; Rajendran et al., 2014).
Recently, several studies demonstrated the participation of exosomes in reciprocal
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oligodendrocyte–neuron communication and delivery of vesicles from oligodendrocytes
to neurons (Frühbeis et al., 2013a, b, and 2014). Other studies have also proved that
exosomes have been participated in communication of neuron-neuron (Chivet et al., 2013
and 2014), neuron-glia (Bahrini et al., 2015; Frühbeis et al., 2013), and glia-glia (Fitzner
et al., 2011). Our observations that small RNAs were enriched in SCN2.2 derived
exosomes, which were readily taken up by fibroblast cells, suggest SCN2.2 cells may
potentially exert miRNA-mediated biological effects on other cells through the secretion
of exosomes. However, the biological function of secreted exosomes from circadian
clock cells remains to be determined.
We have defined the protein contents in exosomes secreted from SCN2.2 cells by
nano-LC-MS/MS method. A total of 79 proteins in SCN-derived exosome were
identified. Compared to those described in other exosomes by searching within databases
such as Vesiclepedia and Excarta (Keerthikumar et al., 2015; Kim et al., 2014), 73
proteins (92%) in SCN-derived exosomes were reported in exosomes isolates of various
cell types. Most of SCN-derived exosomal proteins display unique characteristics with
respect to compositions of many functional categories of proteins. The most frequently
identified proteins in exosomes are proteins involved exosome biogenesis, membrane
associated proteins, transmembrane proteins (adhesion molecules, tetraspanins (CD9,
CD63, CD81), cytoskeletal proteins (actin and syntenin), chaperones (HSP 70, HSP90),
metabolic enzymes (GAPDH) and among others (Chaput and Théry, 2011; Mathivanan et
al., 2012; Théry et al., 2006; ), which is consistent with our study. Nonetheless, cortical
neurons have been reported to release exosomes containing tubulin, actin, clathrin heavy
chain, ubiquitin and metabolic enzymes such as pyruvate kinase and GAPDH ( Faure et
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al., 2006; Hooper et al., 2012), similar to those proteins found in the SCN2.2 cells
derived exosomes described in this study. This suggests that a number of common
proteins are found in exosomes originating from different sources. In fact, the presence of
metabolic enzymes in exosomes appears to be characteristic of such vesicles from a
variety of cell types (Mathivanan et al., 2010). Heat shock proteins (HSP 70 and HSP 90)
are also found in exosomes from different cells (Chavez-Munoz et al., 2009; Simpson et
al., 2008), which is consistent with our findings.
The protein contents of SCN2.2 cell-derived exosomes includes both a ubiquitous
and a cell type-specific composition. Several proteins not previously described in
exosome database were found in this study including Acyl-coenzyme A thioesterase 12
isoform X1, Hist1h3a isoform X2, Pyruvate kinase PKM isoform X1, and netrin-1
precursor. Interestingly, netrin-1 has been found to play a critical role during nervous
system development, and has been involved in regulation of oligodendrocyte process
branching and membrane extension (Serafini et al., 1994; 1996). Netrin-1 is the founding
member of the netrin family that was the first axon guidance cue (Finci et al., 2015).
However, the function of netrin-1 has not been reported in circadian clock system. It was
shown that one of proteins identified in SCN-derived exosomes was carbamoylphosphate synthase (CPS), which was only identified in exosomes secreted from
hepatocyte (Conde-Vancells et al., 2008). Intriguingly, expression of CPS has showed
robust circadian rhythm in mouse liver (Reddy et al., 2006). CPS plays very important
role in the urea cycle, and acts at the rate-limiting step in ureagenesis by converting
ammonia to carbamoyl phosphate (Reddy et al., 2006). The mice genetically lacking CPS
die in early development due to the accumulation of overload ammonia, and mutations in
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cps1 are associated with liver disorders in humans (Reddy et al., 2006; Schofield et al.,
1999).
In conclusion, this study demonstrated the presence of exosomes in the paracrine
secretion of SCN2.2 cells. Our results showing that SCN-derived exosomes can be
delivered into fibroblast cells strength the hypothesis that exosomes might present a novel
way for intercellular communication in circadian clock system. We anticipate that this
project will yield valuable information on the identity of output signals that mediate SCN
pacemaker function and their specificity in coordinating oscillations across different cell
or tissue types. More work is now required to examine the effect of SCN-derived
exosomes on the coordination of circadian rhythmicity in fibroblast cells.
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CHAPTER III
COMPARATIVE ANALYSES OF DIFFERENTIAL MICRORNA EXPRESSION
PROFILES BETWEEN EXTRACELLULAR AND INTRACELLULAR
COMPONENT OF SCN2.2 CELLS

3.1

Abstract
Suprachasmatic nuclei cells (SCN2.2) are crucial in mammalian clock pacemaker,

and secret soluble factors that drive oscillation of peripheral tissues or cells. The
mechanisms of the synchronization are not fully understand, however, extracellular
miRNAs may play an important role to control the circadian clock rhythm, because
miRNAs are regulatory non-coding small RNAs that can bind to complementary regions
of messenger RNAs to repress their translation. Extracellular vesicle-mediated
communication has been implicated in the intercellular transferring of miRNAs in
circadian clock. Thus, this study explored the miRNA expression profile between
extracellular matrix, including SCN2.2 cell-derived exosome and exosome-depleted
conditioned media (EDCM), and intracellular component of SCN2.2 cells using Illumina
HiSeq 4000 and bioinformatics analyses. Small RNAs from exosome, EDCM and cells
have been isolated with different kits, and measured for quality with a Bioanalyzer. We
have assembled a quantitative miRNA expression profiles between intracellular (SCN2.2
cells) and extracellular (SCN-derived exosomes and EDCM through the use of small
RNA deep sequencing. The profiling data shows that expression profiles of extracellular
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miRNAs in both exosomes and EDCM are significantly different from their parental
cells. We have identified 71 unique exosomal miRNAs and 270 unique miRNAs in
EDCM by differential expression (DE) analyses. In particular, miR-34c-5p, miR494-5p,
miR142, and let-7 in exosomes have been reported to be involved in circadian gene
expression. Additionally, Several DE miRNAs in EDCM including miR-122, miR-155,
miR-219, miR-200 and miR-375 were reported to target circadian clock genes such as
Per2, Bmal1/2, Clock, and Cry1/2. Interestingly, both miR-155 and miR-29, which were
significantly higher in exosomes and EDCM than in SCN2.2 cells, have been reported to
directly involve in circadian clock system.
Through the comparison of the miRNA expression profiles in extracellular fluids,
including exosomes and EDCM, and intracellular part of SCN2.2 cells, we have
identified several candidate miRNA which are associated with in the regulation of
circadian clock system. More work need to be done to explore the pathway and
functional role of extracellular miRNA, which regulate circadian rhythmicity in
peripheral tissues by facilitating cell to cell communication.
3.2

Introduction
MicroRNAs (miRNA) are ~22 nt endogenous, noncoding RNA, which play an

important role in regulatory of messenger RNA transcription in both animals and plants
(Bartel, 2009). miRNAs can bind to the target mRNA by base paring, which provides a
convenient strategy to control the expression of a miRNA and the production of protein.
The same miRNA can regulate different mRNAs’ transcription, and also different
miRNAs can regulate the same mRNA’s transcription. The first identified miRNA is lin4, which known to control the timing of developmental transitions (Lee et al., 1993). For
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several years after the discovery of the lin-4, there are many new miRNA were found
from flies, worms, and human (Lagos-Quintana et al., 2001; Lau et al., 2001; Lee and
Ambros, 2001). There are more than 2,000 identified human miRNA that have been
found to affect gene regulation in essential biological pathways (Croce and Calin, 2005).
The biogenesis of miRNA in mammalian has been reported in detail. miRNAs are
managed from primary transcripts into ∼70-nt hairpin precursors (pre-miRNA) (Lee et
al., 2002; Zeng and Cullen, 2003) in the nucleus by Drosha RNase III endonuclease that
cleaves the stem at sites near the primary stem loop (Lee et al., 2003). The pre-miRNA is
then transported to cytoplasm from nucleus by Ran-GTP and Exportin-5 (Yi et al., 2003;
Lund et al., 2004). In the cytoplasm, the pre-miRNA is cleaved by another enzyme Dicer,
which is also an RNase III endonuclease (Kim, 2005; Lee et al., 2003). The ~22-nt
fragments are the functional (Kim, 2005). Micro RNAs are derived from the intracellular
origin, and can be secreted either by extracellularly bound to lipoproteins (Arroyo et al.,
2011) or cell-derived exosomes as a method of cell-to-cell communication (Valadi et al.,
2007). Compared to the miRNAs bound to lipoproteins, the miRNAs secreted by
exosomes are more stable, because they are protected by exosome bilayer membrane
(Cheng et al., 2014). Mature mammalian miRNAs bind to their specific target sequences
on the 3’-untranslated region (3’-UTR) of mRNAs by imperfect base pairing, leading to
mRNA cleavage or translational repression (Yekta, Shih, and Bartel, 2004; Kloosterman
and Plasterk, 2006). Because one miRNA may have hundreds of target mRNAs, each
miRNA has wide-reaching effects on gene expression, and together with their target
mRNAs they form non-linear gene regulatory networks.
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miRNAs have various functions, including regulation of neuronal development
and differentiation, synapse formation precursorand plasticity (Kloosterman, and
Plasterk, 2006; Fiore and Schratt, 2007; Presutti et al., 2006). The expression levels of
miRNAs seem to be dynamic while they are also regulated by environmental stimuli
(Rinaldi et al., 2010). Therefore, miRNAs have been investigated a lot in several
diseases, including Alzheimer's disease (Lukiw et al., 2007), Parkinson's disease (Kim et
al., 2007), schizophrenia (Perkins, 2007), and aggressive behavior (Jensen et al., 2009).
miRNAs are considered as biomarkers in a variety of diseases, such as cancer, heart
disease, infection.
In mammals, the suprachiasmatic nuclei (SCN) of the hypothalamus is the
pacemaker of circadian clock, which allows organisms to adapt their physiological and
behavioral process to a cycle about 24 hours (Reppert and Weaver, 2001). CLOCK,
BMAL1, period (per1 and per2), and cryptochrome (cry1 and cry2) are circadian clock
genes that drive rhythmic expression of critical clock components. The function of
miRNA is to regulate other gene expression, thus, miRNA represent a novel way to
regulate biological timing system.
With the advances in next-generation deep sequencing (NGS), both the known
and novel miRNA can be profiled with minimal RNA input (Cheng et al., 2014).
Therefore, the analysis of microRNA from exosomes and EDCM are easier than before.
Exosomes are isolated from SCN2.2 cells’ conditioned media, which is SCN2.2 cultured
media, with differential ultracentrifugation combined with filtration. With NGS, we set
out to profile miRNA samples from SCN2.2 cells, SCN2.2 cell-derived exosomes, and
SCN2.2 conditioned media.
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Our hypothesis is that extracellular matrix of SCN2.2 cells including exosome and
EDCM have differential expression of miRNA compared to their parental cells.
Following experiments were conducted to characterize DE miRNAs by: 1) extracting
small RNA and checking the quality of small RNAs from samples; 2) determining the
miRNA contents in samples by small RNA sequencing; 3) evaluating DE miRNAs
between extracellular and intracellular components.
3.3
3.3.1

Material and Methods
Cell lines and culture reagents
Rat circadian clock cell line SNC2.2 was obtained from Dr. David Earnest from

Texas A&M Health Science Center (College Station, Texas). The cells from SCN2.2 cell
line (passages 15 and 16) were seeded on laminin-coated culture dishes (60 mm; Corning,
Corning, NY) and maintained at 37°C and 5% CO2 in minimum essential medium
(MEM) supplemented with 10% FBS (HyClone laboratories, Inc., UT, USA), 3,000
µg/ml glucose, and 292 µg/ml l-glutamine (all supplemented products were from Gibco
of Thermofisher.com, Carlsbad, CA, USA). At 48-h intervals, the medium were changed
and cultures were split at 1:3 or 1:4. Before experimental analysis, cultures were plated
on multiple flasks (75 cm2) coated with poly-D-lysine and laminin. At 24h after plating,
the culture medium was changed so as to, respectively, reduce the 10% FBS
concentration to 5%. To facilitate cell cycle and circadian clock synchronization across
cultures, cells were subjected to medium replacement and exposed to serum-free
neurobasal medium (NM) supplemented with 3,000 µg/ml glucose, 292 µg/ml lglutamine, and 1× B-27 serum-free supplement. Cultures were rinsed and thereafter
maintained in serum-free neurobasal medium with supplements for 24 h.
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3.3.2

Conditioned media (CM) collection, exosome isolation and SCN2.2 cells
collection
As shown in Figure 3.1, CM of SCN2.2 cells grown as described above were

collected, and immediately centrifuged at 2000 x g for 20 minutes to remove any cell
debris. Supernatant was collected and transferred to ultracentrifuge polyallomer tubes
(Beckman Coulter, Brea, CA, USA). Samples were then centrifuged again at 10,000 x g
for 30 minutes at 4°C, in order to pellet larger apoptotic bodies and microvesicles.
Supernatant was then collected, and transferred to new ultracentrifuge tubes followed by
filtration of 0.22µm filters (EMD Millipore, Billerica, MA, USA). Exosomes were
pelleted by ultracentrifugation at 100,000 x g for 2 hours at 4°C with a Type SW27 rotor
(L-50 ultracentrifuge; Beckman Coulter, Brea, CA, USA). The pelleted exosomes were
pooled, washed once in PBS pH 7.3, and were centrifuged again by 100,000 x g for 2
hour (SW50.1 rotor, L-50 ultracentrifuge; Beckman Coulter). Exosomes were
resuspended in 100 µL PBS, or in lysis buffer (Total exosome RNA/Protein extraction
kit, Lifetechnolgies, Carlsbad, CA, USA), depending on the downstream assays. The resuspended samples were stored at -80°C, if not immediately used.
Typical yields of exosomes were 1600 particles per SCN 2.2 cell. After removal
of CM for exosome isolation, the pellets of SCN 2.2 cells were also collected by trypsin
degradation, and centrifuged at 850 x g for 5 minutes. The cell pellets were snapped
frozen in liquid nitrogen and stored at -80C for later small RNA isolation, as described
below.
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3.3.3

Small RNA extraction and quantification
Exosome small RNA was isolated with Total Exosome RNA and Protein Isolation

Kit (Life Technologies, Carlsbad, CA, USA) according to the manufacturer’s instruction.
Briefly, exosome pellets from 500 ml SCN2.2 condition media were mixed with 200 µl
Exosome Resuspension Buffer, and the mixture was processed according to the
manufacturer’s protocol. All exosome’s small RNA samples were eluted into 35 µl of
RNase free water.
Cell small RNA was isolated with mirVana PARIS Kit (Life Technologies,
Carlsbad, CA, USA). SCN2.2 cell pellets were mixed with 300 µl Cell Disruption Buffer,
and the mixture was processed according to the manufacturer’s protocol. All cell’s small
RNA samples were eluted in 35 µl of RNase free water.
EDCM small RNA was isolated by TRIzol LS Kit combined with Qiagen’s
miRNeasy Mini Kit and miRNeasy MiniElute Kit (Qiagen, Valencia, CA, USA)
according to the manufacturer’s protocols. Total RNA was isolated from EDCM with the
manufacturer’s protocol for TRIzoI® LS Reagent (Life Technologies, Carlsbad, CA,
USA). Total RNA was washed with 75% ethanol and resuspended in RNase free water.
Small RNA was enriched with Qiagen’s miRNeasy Mini Kit using the RNeasy Mini spin
column. Then miRNA was enriched and purified using Qiagen’s miRNeasy MiniElute
Kit with RNeasy Min Elute spin column. All EDCM’s small RNA samples were eluted
into 10 µl of RNase free water. All small RNAs from exosomes, cells and EDCM were
quantitated with an UV-Vis spectrophotometer (Nanodrop 2000; NanoDrop
Technologies, Wilmingtion, DE) and analyzed with the Agilent Bioanalyzer 2100
(Agilent Technologies, Santa Clara, CA).
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Figure 3.1

Schematic diagram showing the workflow of small RNA extraction.

Small RNA was isolated from EDCM, exosome, and cell using different kits. To isolate
small RNA, three different kits were combined for EDCM. TRIzol LS Kit was used to
isolate total RNA from EDCM. Total RNA was then purified and enriched by miRNeasy
Mini Kit and miRNeasy MiniElute Kit.
3.3.4

Small RNA library preparation
Following small RNA isolation from exosome, cell, and EDCM, small RNA

libraries were prepared using the NEBNext Multiplex Small RNA Library Prep Set for
Illumina Kit (Set 1 and Set 2) (New England Biolabs, Ipswich, MA) according to the
manufacturer's instructions. The reason we chose these kits is that it results a higher
yields and lower adaptor-dimer contamination. These two kits are actually identical but
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supplied with different index primers, each kit contains 12 different index primers.
Briefly, for each library preparation, 100ng of small RNA was used at the beginning of
library preparation. Input small RNAs were ligated by 3′ adapters first, and then the
reverse transcription primer was hybridized to prevent adaptor-dimer formation. After
primer hybridization, input small RNAs with 3’ adapters were ligated by 5’ adapters.
Reverse transcription was performed following the both adapters ligation to synthesize
the first strand cDNA. cDNA was amplified with PCR using 5’-universal primer and 3’index primer. Each enriched small RNA library was then indexed with unique barcoded
sequence, which was used for the multiplexing purpose. All enriched small libraries were
purified by QIAQuick PCR Purification Kit and eluted in 28µl Nuclease-free Water. To
remove large fragments, the cleanup library products were size-selected using AMPure
XP beads (Beckman Coulter, Brea, CA) following the size selection protocol from the
manufacturer’s instruction. The final library samples were quantified by the Qubit
flourometer using Qubit dsDNA HS Assay Kit (Life Technologies, Carlsbad, CA) and
validated by Agilent Bioanalyzer 2100 system using DNA 1000 assay kit (Agilent
Technologies, Santa Clara, CA).
3.3.5

Sequencing of small RNA libraries
To multiplex the library samples, all small RNA library samples were diluted to

equal concentration and pooled together with equal amount, which considered as one
sequencing sample. The pooled 15 small RNA library samples were processed: six
exosome small RNA samples with NEBNext Multiplex Small RNA Library Prep (New
England Biolabs, Ipswich, MA) barcodes # 9, 10, 11, 19, 20, 21; three cell samples with
NEBNext Multiplex Small RNA Library Prep (New England Biolabs, Ipswich, MA)
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barcodes # 22, 23, 24; six EDCM samples with NEBNext Multiplex Small RNA Library
Prep (New England Biolabs, Ipswich, MA) barcodes # 13, 14, 15, 16, 17, 18. The pooled
sample was sequenced on an Illumina HiSeq 4000 (Illumina, San Diego, CA) with 1 lane
of 1x50 (single end 50 bp or SE50) sequencing method. Each library sequence reads can
be identified by different barcodes.

Figure 3.2

Schematic diagram showing the workflow of small RNA library preparing
and sequencing analysis.

Small RNA isolated from condition media supernatant (EDCM), exosome, and cell was
ligated with 3’ and 5’ adaptors, and amplified by PCR, and quantified. The small RNA
samples were pooled to one sequencing sample that was sequenced by Illumina HiSeq
System with single end 50 bp (1 x 50) sequencing (Illumina, San Diego, CA). The
sequencing data was mapped to known miRNA, and normalized to compare with cell.
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3.3.6

Small RNA deep sequencing and bioinformatics analysis
The pooled samples were demultiplexed into individual files according to the

different indexes. Only reads with an index sequence were reserved. Raw reads were
trimmed by removing the bad quality sequence, index sequence, Illumina adaptor
sequence, and the sequence reads shorter than 15 bp. The resulting set of trimmed reads
were then mapped against the miRNA database of all species in miRBase
(http://www.mirbase.org/), which is the mature reads, and also mapped against the
miRNA database of rat in miRBase (http://www.mirbase.org/), which is the rno-maturereads. MiRNAs detected that matched to only one miRNA, which is unique reads, were
used to do the further analysis. EdgeR was used to analyze the differential expression of
miRNA. EdgeR can moderate common dispersion of miRNA-Seq data. Count numbers
of each miRNA were imported to EdgeR, log2 transformed, and normalized miRNA
expression levels. Differential expression of miRNAs between exosome and cell, and
between EDCM and cell were assessed in EdgeR by calculating an exact test p-value
analogous to the Fisher’s exact test (Juhila et al. 2011). The final differentially expressed
miRNAs were further filtered by the fold change > 2 (up-regulated and down-regulated),
and both P value and FDR < 0.05.
3.4
3.4.1

Results
Small RNA extraction and qualification
Exosome small RNA was isolated using Total Exosome RNA and Protein

Isolation Kit from Life Technology (Life Technology, Carlsbad, CA) according to the
manufacturer's instructions. Small RNA from SCN2.2 cells were isolated using mirVana
PARIS Kit (Life Technology, Carlsbad, CA) according to the manufacturer’s instruction.
96

Small RNA from CM, SCN2.2 cells and SCN2.2 cell-derived exosomes were analyzed
using an Agilent Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA) with the
Agilent Small RNA Assay kit that available for analysis of low concentration sample.
NanoDrop 2000 also can be used to measure the small RNA concentration. However,
compared to the Agilent Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA), it is
not sensitive enough to measure the purified small RNA concentration. The Agilent
Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA) profiles showed that cell,
exosome, and EDCM include different ration of miRNA to small RNA. The results show
that exosome has 58% miRNA, cell has 28% miRNA, and EDCM has 51% miRNA.
Exosome small RNA electropherogram picture shows many little peaks between 4 nt to
150 nt, and many bands on the gel picture. EDCM small RNA electropherogram picture
reveals three major peaks around 30 nt, 60 nt and 70 nt, and three clear bands on the gel
picture. Cell small RNA electropherogram picture just show one clear peak between 40 nt
to 80nt, and one concentrated band on the gel picture. Small RNA contain many different
types RNA: miRNA (19–25 nt), U7 small nuclear RNA (63 nt), tRNA (73 nt), and vault
RNA (100 nt). Compared to cell, exosome and EDCM have higher percentage of
miRNA. The small RNA concentration of exosome, cell, and EDCM is different:
exosome small RNA concentration is 19898.10 pg/µl, cell small RNA concentration is
6739.50 pg/µl, and CM small RNA concentration is 19645.90 pg/µl.
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Figure 3.3

Analysis of small RNA isolated from SCN2.2 cell-derived exosome,
SCN2.2 cell, and EDCM using an Agilent Bioanalyser 2100 system with
the Agilent Small RNA Assay Kit.

Representative Gel (left) and electropherogram image (right) of (A) exosome derived
from SCN2.2 cell, (B) SCN2.2 cells, and (C) EDCM are shown. On the electropherogram
image, Y axis is the arbitrary fluorescence unit intensity (FU), X aixs is small RNA size
(nt). Exosomal miRNAs occupied 58% of total small RNA with size range from 17 to
200 nts (A). However SCN2.2 miRNA is 26% of total small RNA, with majority of small
RNA concentrated on the size between 50 nt to 70 nt (B). In addition, EDCM miRNA
consists of 51% of total small RNA. There were three peaks on the electropherogram
image, which corresponded the length of 30 nt, 60nt, and 70nt.
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3.4.2

Qualitative analysis of micro RNA
All the libraries were analyzed using Illumina HiSeq 4000 (Illumina, San Diego,

CA). Millions total reads per library were reported (Table 3.1). In Table 3.1, the reads
number is less and less through different filters. The total reads is reads number of all
the sequence detected in sample library. After receiving the total reads, the data was
initially trimmed by removing the index sequence, adaptor sequence, bad quality
sequence, and also the sequence less than 15 bp, and eventually named as the
surviving reads. Surviving reads were mapped against the miRNA database from all
species in miRBase (http://www.mirbase.org/), which is called mature reads. miRBase
is the public ordnance for all published miRNA sequences and associated annotation.
Rno-mature reads are the known miRNAs mapped against rat miRNA database in
miRBase. Finally, the unique reads was reported, which is known miRNA from the
rno-mature reads that exactly matched to just one miRNA sequence according to the
rat miRNA database. Compared the unique reads from three different sample types,
libraries from EDCM contain less reads than those from cell and exosome samples.
The unique reads were used to do the further analysis. There are total 765 different
types of published rno-mature RNAs in cells, exosomes, and EDCM. These different
types’ miRNAs have different length, which is from 17 nt to 25 nt. Among all of the
identified rno-mature miRNAs, 22 nt-long miRNAs accounted for the highest
proportions of 46.14% in the total number of different length groups (Figure 3.3). The
length of 21 nt and 23 nt groups are 21.57% and 16.34% of the total number of
different length groups. The remianing is 15.95%. Figure 3.6 shows the top 15
abundance miRNA in cell, exosome, and EDCM. The total average rno-mature reads
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of cell, exosome, and CM are 9.2 x 10^6, 8.3 x 10^6, and 2.0 x 10^6. Among the top
15 abundance miRNAs from three groups, there are 11 same miRNA, which are miR21-5P, miR-143-3p, let-7i-5p, miR-10a-5p, miR-26a-5p, miR-30a-5p, let-7g-5p, let7f-5p, miR-99a-5p, miR-22-3p, and miR-3596d; exosome has 2 unique miRNA,
which are let-7c-5p and miR-24-3p; cell has 1 unique miRNA, which is miR-30e-5p;
EDCM has 3 unique miRNA, which are miR-1199-5p, miR-30d-5p, and miR-127-3p.
miR-21-5p is the most abundance miRNA in cells, exosomes and EDCM. The
absolute sequence reads were normalized using EdgeR software, which is designed for
analyzing differential gene expression data.
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Table 3.1

Summary of library read number analysis among SCN2.2 cells, SCN2.2
cell-derived exosomes, and EDCM.

Library ID

Total readsᵃ
(10^6)

Surviving
readsᵇ(10^6)

Mature
readsᶜ (10^6)

Rno-mature
readsᵈ (10^6)

Cell-1
Cell-2
Cell-3
Exosome-1
Exosome-2
Exosome-3
Exosome-4
Exosome-5
Exosome-6
EDCM-1
EDCM-2
EDCM-3
EDCM-4
EDCM-5
EDCM-6

15.64
16.85
18.49
13.71
20.05
16.90
18.46
17.33
20.77
23.50
22.93
17.14
15.63
17.03
17.08

14.77
15.77
16.98
9.43
18.46
15.71
17.27
15.68
16.44
20.68
20.69
16.26
15.00
16.09
16.84

9.56
10.47
10.98
5.18
11.50
10.64
10.60
9.21
9.42
4.87
4.62
3.33
2.76
2.75
1.89

8.53
9.26
9.87
4.62
10.45
9.85
9.60
7.81
7.33
2.90
2.69
2.06
1.79
1.84
0.93

Unique
readsᵉ
(10^6)
6.04
6.32
6.68
2.87
7.71
7.35
6.87
5.42
4.35
1.32
1.27
1.02
0.75
0.85
0.34

a: the total read number of the whole library
b: the read number of the sequence with good quality and size larger than 15 bp
c: the read number of known miRNAs mapped against all species miRNA database in
miRBase
d: the read number of known miRNAs mapped against just rat miRNA database in
miRBase
e: the read number of the sequence just match one miRNA of rat miRNA database in
miRBase
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Figure 3.4

Average unique reads of SCN2.2 cells, SCN2.2-derived exosomes and
EDCM.

The unique reads are the sequence just match one miRNA of rat miRNA database in
miRBase. Exosome average unique reads from six replicate small RNA libraries. SCN2.2
cells average unique reads from three replicate small RNA libraries. EDCM average
unique reads from six replicate small RNA libraries. SCN2.2 cells and exosomes have
more unique reads than EDCM unique reads.
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Figure 3.5

Length distribution of mature RNAs in SCN2.2 cells, SCN2.2 cell-derived
exosomes, and EDCM. SCN2.2 cells, exosomes, and EDCM overlap all of
the mature RNA types.

765 mature RNAs were identified in cells, exosomes, and EDCM. The length range of
the identified mature RNAs is from 17 nt (nucleotide) to 25 nt. The length of 22 nt
miRNAs accounted for the highest proportions is 46.14% of the total different length
number. The length of 21 nt and 23 nt are 21.57% and 16.34% of the total different
length number. The other length is 15.95% of the total different length number.
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A

Figure 3.6

Top 15 abundance of mature average surviving reads of SCN2.2 cells (A),
SCN2.2 cell-derived exosomes (B), and EDCM (C).
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B

Figure 3.6 (Continued)
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C

Figure 3.6 (Continued)
The total average rno-mature reads of SCN2.2 cells, SCN2.2-derived exosomes, and EDCM are
9.2 * 10^6, 8.3 * 10^6, and 2.0 * 10^6. Among the three groups, there are 11 same miRNA,
exosome has 2 unique miRNA, cell has 1 unique miRNA, and EDCM has 3 unique miRNA.
miR-21-5p is the most abundance miRNA in cells, exosomes and EDCM.

3.4.3

Quantitative analysis of micro RNA
Differential expression (DE) of miRNAs between SCN2.2 cell-derived exosomes

and SCN2.2 cells, and between EDCM and SCN2.2 cells were assessed with EdgeR
software, which moderates common dispersion in miRNA-Seq data. The differential
expression is set up by fold change > 2 (up-regulated and down-regulated at least 2 times)
and both P value and FDR (False Discovery Rate) < 0.05. Table 3.2 shows the summary
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of total DE miRNA involved in SCN2.2 cell-derived exosomes and EDCM compared to
SCN2.2 cells. SCN2.2 cell-derived exosomes contain 152 DE miRNA, including 69 upregulated miRNA and 83 down-regulated miRNA. EDCM have 351 DE miRNA, in
which 309 miRNA are up-regulated and 42 miRNA are down-regulated. Compared to the
total DE miRNA of exosome and EDCM, there are 81 same miRNA between the two
groups, exosome has 71 miRNA different from EDCM that is 46.71% of exosome total
DE miRNA, and EDCM has 270 miRNA different from exosome that is 76.92% of
EDCM total DE miRNA (Figure 3.5). Table 3.3 reveals that exosome contain 23 upregulated (Table 3.4) and 48 down-regulated miRNA in the unique miRNA, and EDCM
contain 238 up-regulated and 32 down-regulated miRNA in the unique miRNA. The upregulated miRNA and down-regulated miRNA are 32.39% and 67.61% of exosomal total
unique miRNA, respectively; whereas the up-regulated and down-regulated miRNA are
88.15% and 11.85% of EDCM’s total unique miRNA.

Table 3.2

Summary of total DE* miRNA between extracellular (SCN2.2 cell-derived
exosomes and EDCM) and intracellular (SCN2.2 cells).

Total DE miRNA
Up-regulated
Down-regulated
152
69
83
Exosome vs. cell
351
309
42
EDCM vs. cell
Differentially expressed (DE) miRNA is filtered by fold change > 2 and both P value and
FDR (False Discovery Rate) < 0.05. Compared to cells, there are up-regulated and down
regulated DE miRNA in both exosomes and EDCM.
DE*: differentially expression
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EDCM

Figure 3.7

Venn diagram showing DE miRNA from SCN2.2-derived exosome and
EDCM.

Exosome has total 152 DE miRNA, and EDCM has total 351 DE miRNA. Exosome and
EDCM have 81 common DE miRNA, exosome include 71 unique DE miRNA, and
EDCM include 270 unique DE miRNA.

Table 3.3

Summary of unique DE* miRNA between extracellular (SCN2.2 cellderived exosomes and EDCM) and intracellular (SCN2.2 cells).

Unique
Up-regulated
Down-regulated
71
23
48
Exosome vs. cell
270
238
32
EDCM vs. cell
Differentially expressed (DE) miRNA is filtered by fold change > 2 and both P value and
FDR (False Discovery Rate) < 0.05. There are 23 up-regulated and 48 down-regulated
DE miRNA in exosome unique DE miRNA. There are 238 up-regulated and 32 downregulated DE miRNA in EDCM unique miRNA.
DE*: differentially expression
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Table 3.4

Summary of 15 top up-regulated unique DE miRNA in SCN2.2 cellderived exosomes (Fold change > 2 and both P value and FDR (False
Discovery Rate) < 0.05).

miRNA ID
rno-miR-22-5p
rno-miR-218a-5p
rno-miR-24-3p
rno-miR-378a-5p
rno-miR-24-2-5p
rno-miR-146b-5p
rno-miR-1843a-5p
rno-miR-148b-5p
rno-miR-217-5p
rno-miR-466b-5p
rno-miR-3120
rno-miR-224-5p
rno-let-7b-5p
rno-let-7c-5p
rno-miR-145-5p

Transcript sequence
AGTTCTTCAGTGGCAAGCTTTA
TTGTGCTTGATCTAACCATGT
TGGCTCAGTTCAGCAGGAACAG
CTCCTGACTCCAGGTCCTGTGT
GTGCCTACTGAGCTGAAACAGT
TGAGAACTGAATTCCATAGGCTGT
TATGGAGGTCTCTGTCTGACT
GAAGTTCTGTTATACACTCAGG
TACTGCATCAGGAACTGACTGG
TATGTGTGTGTGTATGTCCATG
CACAGCAAGTGTAGACAGGCA
CAAGTCACTAGTGGTTCCGTTT
TGAGGTAGTAGGTTGTGTGGTT
TGAGGTAGTAGGTTGTATGGTT
GTCCAGTTTTCCCAGGAATCCCT

FC*: Fold change

109

logFC*

Fold change

1.04
1.12
1.15
1.16
1.16
1.17
1.17
1.29
1.38
1.41
1.45
1.49
1.60
1.78
1.82

2.06
2.18
2.22
2.23
2.24
2.25
2.25
2.45
2.60
2.66
2.74
2.82
3.03
3.42
3.54

Table 3.5

Summary of 15 top down-regulated unique DE miRNA in SCN2.2 cellderived exosomes (Fold change > 2 and both P value and FDR (False
Discovery Rate) < 0.05).

miRNA ID
rno-miR-1b
rno-miR-451-3p
rno-miR-133b-3p
rno-miR-26a-3p
rno-miR-3548
rno-miR-3595
rno-miR-133a-3p
rno-miR-3571
rno-miR-449c-3p
rno-miR-3084c3p
rno-miR-376a-5p
rno-miR-494-5p
rno-miR-741-3p
rno-miR-105
rno-miR-1912-3p

Transcript sequence
TGGAATGTAAAGAAGTATGTAT
ATGGTAATGGTTCTCTTGCTGCT
TTTGGTCCCCTTCAACCAGCTA
CCTATTCTTGGTTACTTGCAC
CAGCACTGTCCGGTAAGATGCC
GTGGATTTTCCTCTACGAT
TTTGGTCCCCTTCAACCAGCTG
TACACACTTCTTTACATTCCATA
TAGAACTTCGTCCCAAC

logFC*

Fold change

-5.88
-3.62
-3.37
-3.28
-3.13
-3.12
-3.00
-2.91
-2.83

0.02
0.08
0.10
0.10
0.11
0.11
0.12
0.13
0.14

CTGCCAGTTCCCTTCAGACAA

-2.83

0.14

GGTAGATTCTCCTTCTATGAG
AGGTTGTCCGTGTTGTCTTCTC
AAAGATGCCACGCTATGTAGAT
CAAGTGCTCAGATGTCTGTGGT
CACAGAACATGCAGTGAGA

-2.80
-2.72
-2.68
-2.59
-2.58

0.14
0.15
0.16
0.17
0.17

FC*: Fold change
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Table 3.6

Summary of 15 top up-regulated unique DE miRNA in EDCM (Fold
change > 2 and both P value and FDR (False Discovery Rate) < 0.05).
miRNA ID

rno-miR-345-3p
rno-miR-298-5p
rno-miR-361-5p
rno-miR-19b-3p
rno-miR-219a-13p
rno-miR-15b-3p
rno-miR-423-3p
rno-miR-3473
rno-miR-449a-5p
rno-miR-505-5p
rno-miR-144-3p
rno-miR-181b-5p
rno-let-7b-3p
rno-miR-3590-5p
rno-miR-3586-3p

Transcript sequence
CCCTGAACTAGGGGTCTGGAGA
GGCAGAGGAGGGCTGTTCTTCCC
TTATCAGAATCTCCAGGGGTAC
TGTGCAAATCCATGCAAAACTGA

logFC*

Fold change

1.06
1.06
1.15
1.15

2.08
2.09
2.22
2.22

AGAGTTGCGTCTGGACGTCCCG

1.18

2.27

CGAATCATTATTTGCTGCTCTA
AGCTCGGTCTGAGGCCCCTCAGT
TCTAGGGCTGGAGAGATGGCTA
TGGCAGTGTATTGTTAGCTGGT
GGGAGCCAGGAAGTATTGATGTT
TACAGTATAGATGATGTACT
AACATTCATTGCTGTCGGTGGGT
CTATACAACCTACTGCCTTCCC
TGCCCTTTTAACATTGCACTG
ATACTAGACTGTGAGCTCCTCGA

1.19
1.21
1.22
1.24
1.25
1.31
1.32
1.34
1.34
1.34

2.27
2.31
2.32
2.36
2.38
2.48
2.49
2.53
2.54
2.54

FC*: Fold change
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Summary of 15 top down-regulated unique DE miRNA in EDCM (Fold
change > 2 and both P value and FDR (False Discovery Rate) < 0.05).

Table 3.7

miRNA ID

rno-miR-27a-5p
rno-miR-465-5p
rno-miR-628
rno-miR-434-3p
rno-miR-92a-1-5p
rno-miR-6331
rno-miR-195-3p
rno-let-7c-1-3p
rno-miR-331-5p
rno-miR-9a-5p
rno-miR-347
rno-miR-452-3p
rno-miR-340-3p
rno-miR-1-3p
rno-miR-374-3p

Transcript sequence
AGGGCTTAGCTGCTTGTGAGCA
TATTTAGAACGGTGCTGGTGTG
ATGCTGACATATTTACGAGAGG
TTTGAACCATCACTCGACTCCT
AGGTTGGGATTTGTCGCAATGCT
CTTTGGTGGCTTAGTTCTTTGTGC
CCAATATTGGCTGTGCTGCTCCA
CTGTACAACCTTCTAGCTTTCC
GGTCTTGTTTGGGTTTGTT
TCTTTGGTTATCTAGCTGTATGA
TGTCCCTCTGGGTCGCCCA
TCAGTCTCATCTGCAAAGAAG
TCCGTCTCAGTTACTTTATAGCC
TGGAATGTAAAGAAGTGTGTAT
CTTAGCACGTTGTATTATTATT

logFC*

Fold change

-4.78
-4.77
-4.62
-4.02
-3.01
-2.98
-2.89
-2.72
-2.32
-2.11
-2.10
-2.03
-1.90
-1.86
-1.78

0.04
0.04
0.04
0.06
0.12
0.13
0.13
0.15
0.20
0.23
0.23
0.25
0.27
0.28
0.29

3.00
2.00
1.00
0.00
-1.00
-2.00
-3.00
-4.00
-5.00
-6.00
-7.00
rno-miR-1b
rno-miR-451-3p
rno-miR-133b-3p
rno-miR-26a-3p
rno-miR-3548
rno-miR-3595
rno-miR-133a-3p
rno-miR-3571
rno-miR-449c-3p
rno-miR-3084c-3p
rno-miR-376a-5p
rno-miR-494-5p
rno-miR-741-3p
rno-miR-105
rno-miR-1912-3p
rno-miR-22-5p
rno-miR-218a-5p
rno-miR-24-3p
rno-miR-378a-5p
rno-miR-24-2-5p
rno-miR-146b-5p
rno-miR-1843a-5p
rno-miR-148b-5p
rno-miR-217-5p
rno-miR-466b-5p
rno-miR-3120
rno-miR-224-5p
rno-let-7b-5p
rno-let-7c-5p
rno-miR-145-5p

LogFC

FC*: Fold change

miRNA ID

Figure 3.8

The top 15 Up-regulated and down-regulated unique DE miRNA in
SCN2.2 cell-derived exosomes.
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miR-347
miR-452-3p
miR-340-3p
miR-1-3p
miR-374-3p
miR-345-3p
miR-298-5p
miR-361-5p
miR-19b-3p
miR-219a-1-3p
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miRNA ID

Figure 3.9

3.5

The top 15 Up-regulated and down-regulated unique DE miRNA in
EDCM.

Discussion
Our study revealed the presence of different small RNA patterns between

intracellular (exosomes and EDCM) and extracellular components of SCN2.2 cells. Small
RNA species show different relative distributions among SCN-derived exosome, EDCM,
and CM. Small RNAs are composed of heterogeneous populations including miRNA ,
transfer RNA (Martens-Uzunova et al., 2013), U7 small nuclear RNA (Mowry and Steitz,
1987), U6 small nuclear RNA (Shende et al., 2013), small ILF3/NF90-associated RNA
(Parrott, et al., 2010) ,and vault RNA (Steiner et al., 2006). Majorities of the exosomal
RNAs have been found to be microRNAs, transfer RNA, lncRNA, piwi-interacting RNA,
small nuclear RNA, and small nucleolar RNA (Bellingham et al., 2012; Lötvall et al.,
2014; Nolte-'t Hoen et al., 2012). In our study, the bioanalyzer profiling shows that the
length of exosomal small RNA have an average distribution between 20 to 80 nt, which
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indicate SCN2.2-derived exosomes also contain various species of small RNA. While the
majority of U6 small RNA is indeed located within SCN2.2 cells, it also appears in both
exosomes and EDCM. It has been reported that U6 small RNA is present in SCN2.2 cell
(Shende et al., 2013).
Our differential expression analyses showed the presence of 71 unique miRNA in
SCN-derived exosome, and 270 unique EDCM miRNA, compared to miRNAs in
SCN2.2 cells. It is agreement with our others that miRNAs were found to be expressed to
a greater extent in the exosomes compared to their donor cells (Valadi et al., 2007). In
our study, we found there are 23 up-regulated unique miRNA in exosomes, and there are
238 up-regulated unique miRNA in EDCM. Among those regulation of Drosophila
circadian rhythms by miRNA let-7 is mediated by a regulatory cycle. Interestingly, about
68% of unique exsomal miRNA showed lower expression compared to miRANs in
SCN2.2 cells. Among them, miR34c-5p, miR494-5p and miR-142-5p/3p have been
reported to target circadian clock genes such as Per 2, Bmal, and Reverb (Shende et al.,
2011, 2013 and 2014). Some of the unique and common miRNA have been related to
some unique circadian clock gene. It has suggested that extracellular vesicle-mediated
communication may play an important role in the intercellular transferring of miR-1423p (Shende et al., 2013), which show unique DE (differential expression) in SCN2.2derived exosome in our study. Shende et al. (2013) also found that miR-142-3p levels in
the SCN in vivo and in vitro showed circadian oscillation and may play a role in the
circadian physiology of the SCN by regulating clock gene, Bmal1. There were only 32%
unique DE of exosomal miRNA showing the up-regulation. Especially, rno- let-7 was
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one of DE up-regulated miRNAs in SCN-derived exosomes, which was also found by
Cheng et al. (2014) that Drosophila let-7-Complex, as a regulator of circadian rhythms.
About 88% (238) of DE unique miRNAs in EDCM were up-regulated compared
to unique miRNAs (270) in EDCM. There were 11 miRNAs in this unique up-regulated
group including miR122-3p, miR-155-3p, miR219a-5p, miR219-2-3p, miR-219b, miR196b-5p, miR-375-3p/5p, miR-200a, and miR-200b have been reported in the regulation
of certain genes in circadian clock system (Catfield et al., 2009; Cheng et al., 2007; Han
et al., 2015). Cheng and the coworkers (2007) reported that miR 132 and miR-219 gene
expression in SCN oscillates in a circadian pattern. They demonstrated that miR-219
regulated circadian period length, while miR-132 could modulate light-induced clock
rearranging. In our study, miR-219 and miR-132 were EDCM unique miRNA, which
showed 3 to 4 fold up-regualtion compared to SCN2.2 cells. Han et al. (2015) has
suggested the miR-196 could regulate CRY1/2, Baml2 and Clock genes. They also
demonstrated that miR-375, miR-200a and miR-200b could target CRY2, Bmal1 and
Per2, separately. Only 12% (23) of DE unique miRNAs in EDCM were down-regulated
compared to unique miRNAs (270) in EDCM. The function of miR-155-3p has been
reported in the regulation of molecular clock gene, Bmal 1 (Curtis et al., 2015).
In addition, we have found that three miRNAs, including miR-155-5p and miR129-5p, were up-regulated more than three-fold in both exosomes and EDCM, compared
to those miRNAs in SCN2.2 cells. Curtis et al. (2015) demonstrated that miR-155-5p
targeted Bmal1 and regulate Bmal1 gene expression, in which miR-155 bound to two
different sites located in 3’-untranlated region of Bmal1, leading to suppression of Bmal1
mRNA and protein in mice and humans. Deletion of miR-155 causes perturb in circadian
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function and induces a shorter circadian day. Cheng et al. (2007) showed that miR-132
affected the circadian core clock by modulating Per1 gene transcription and Per2 protein
stability. Light can induce miR-132, then in return that miR-132 modulates the phase
shifting capacity via a MAPK/CREB-dependent mechanism, modulates clock gene
expression. The function of miR-132 have also implicated in fine-tuning the expression
of gene clusters involved in chromatin remodeling and translation control (AlvarezSaavedra et al., 2011)
Since the circadian pacemaking function of the SCN is facilitated by diffusible
factors (Cheng et al., 2002; Hatcher et al., Yang et al., 2001), it is more likely that cell-tocell messengers of time (such as miRNAs in extracellular matrix) coordinate autonomous
circadian clocks in peripheral cells. Taken together, through the comparisons between the
miRNA expression profiles in extracellular fluids, including exosomes and EDCM, and
intracellular part of SCN2.2 cells, we have identified 20 potential miRNAs which might
represent extracellular regulatory signals that could regulate core molecular clockworks.
However, further pathway prediction and functional assay could help us to find out the
key regulatory miRNAs that regulate circadian rhythmicity in peripheral tissues by
facilitating cell to cell communication.
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CHAPTER IV
CONCLUSIONS AND FUTURE PERSPECTIVES

The major objectives of this thesis was to identify whether mammalian pacemaker
SCN could release exosomes in vitro, and characterize the contents of exosomes derived
from SCN2.2 cells by proteomic studies, small RNA sequencing and bioinformatics
analyses. The major conclusions emanating from this thesis are as follows:
(A) SCN2.2 cell-derived exosomes were purified and identified by morphological
and biochemical analyses. About 94% of exosomal proteins were matched to
database, however, there were a few of them were related to either neuronal cellderived exosomes or circadian rhythmicity.
(B) Twenties candidate miRNAs in extracellular components of SCN2.2 cell which
were implicated in the regulation of circadian clock genes.
Exosomes, containing unique miRNA and proteins, have been reported to play
important roles in communication between cells. The work presented in this thesis clearly
demonstrates that SCN 2.2 cells release exosomes (Chapter III), which carry unique
miRNAs (Chapter III) and protein (Chapter II). Those exosomes secreted by SCN2.2 cell
can be taken up by fibroblast cells (Chapter II).
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4.1

Future studies
1) Identify and characterize exosomes released from mammalian SCN tissue in
vivo.
2) Study the role of SCN2.2 cell-derived exosome to see if they can regulate the
clock gene oscillation in downstream fibroblast cells.
3) Explore the role of several specific unique miRNAs found in extracellular
matrix from SCN2.2 cell by miRNA knock-in or knock-out experiment.
4) Analyze the differences of small RNA differential expression profiles between
extracellular (exosome and EDCM) and intracellular part of SCN2.2 cells.
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Table A.1

LC-MSMS results

Sequence ID
NP_062172.1
NP_445756.1
NP_073206.2
XP_006245214.1
NP_446316.1
NP_620796.1
NP_001120921.1
XP_008769908.1
NP_077327.1
NP_001104811.1
NP_036881.2
NP_775125.1
XP_008760958.1
NP_001025192.1
NP_115792.1
NP_001035276.1
NP_113751.3
NP_058834.1
XP_002727490.1
NP_599153.2
NP_001102761.1
NP_058704.1
XP_008769906.1
NP_001008804.1
NP_001264172.1
NP_058878.1
NP_570090.2
NP_062110.1
NP_037025.1
NP_001009239.1
NP_113897.2
NP_063970.1
NP_001037735.1
NP_001008802.2
NP_445940.1
NP_001007601.1
NP_058847.1
NP_001099584.1
NP_001104565.1
NP_001008751.1
NP_446183.2
NP_058848.2

Sequence Name
clathrin heavy chain 1
collagen alpha-1(I) chain precursor
major vault protein
PREDICTED: fibronectin isoform X3
transitional endoplasmic reticulum ATPase
galectin-3-binding protein precursor
actin, cytoplasmic 2
PREDICTED: LOW QUALITY PROTEIN: uncharacterized protein
LOC100910366
heat shock cognate 71 kDa protein
histone cluster 2, H2ab
nucleolin
tubulin beta-5 chain
PREDICTED: collagen alpha-2(I) chain isoform X2
60S acidic ribosomal protein P2
aldehyde dehydrogenase, mitochondrial precursor
lactadherin isoform 1 precursor
nuclease-sensitive element-binding protein 1
40S ribosomal protein SA
PREDICTED: pyruvate kinase PKM isoform X1
serum albumin precursor
H2A histone family, member X
glyceraldehyde-3-phosphate dehydrogenase
PREDICTED: uncharacterized protein Hist1h3a isoform X2
keratin, type I cytoskeletal 10
40S ribosomal protein S5 isoform 1
core histone macro-H2A.1
guanine nucleotide-binding protein subunit beta-2-like 1
procollagen C-endopeptidase enhancer 1 precursor
actin, gamma-enteric smooth muscle
40S ribosomal protein S3
40S ribosomal protein S12
annexin A2
tubulin alpha-1B chain
keratin, type II cytoskeletal 1
collagen alpha-2(V) chain precursor
40S ribosomal protein S4, X isoform
40S ribosomal protein S15
histone cluster 1, H2bo
ATP-citrate synthase isoform 2
keratin, type I cytoskeletal 14
netrin-1 precursor
40S ribosomal protein S17
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gene symbol
CLTC
Col1a1
Mvp
VCP
Lgals3bp
Actg1
HSPA8
Hist2h2ab
NCL
Tubb5
Col1a2
Rplp2
Aldh2
Mfge8
Ybx1
Rpsa
Alb
H2AFX
GAPDH
KRT10
RPS5
H2afy
GNB2L1
Pcolce
ACTG2
Rps3
RPS12
ANXA2
TUBA1B
KRT1
COL5A2
RPS4X
RPS15
Hist1h2bo
Acly
Krt14
Ntn1
Rps17

Table A.1 (Continued)
NP_942025.1
NP_899162.1
NP_001094477.1
XP_003750185.1
NP_112381.2
NP_001007605.1
NP_001004082.3
NP_001011918.1
NP_001026809.1
NP_579819.1
NP_058941.1
NP_112364.1
NP_001099879.1
NP_071797.1
NP_001292806.1
NP_001099489.1
NP_058849.1
NP_001099633.1
NP_037219.1
NP_444177.1
NP_036767.1
NP_001014031.2
NP_001025081.2
NP_112374.1
NP_114180.1
NP_113758.2
NP_001264231.1
NP_001008899.1
NP_036980.1
NP_001009720.1
NP_114192.1
NP_001164067.1
NP_058783.1
NP_073163.1
NP_001099200.1
NP_058768.1
XP_008758850.1

26S proteasome non-ATPase regulatory subunit 6
keratin, type II cytoskeletal 5
keratin, type II cytoskeletal 6A
PREDICTED: laminin subunit beta-1 isoform X2
lupus La protein homolog
60S acidic ribosomal protein P1
heat shock protein HSP 90-beta
annexin A11
26S proteasome non-ATPase regulatory subunit 2
histone H1.4
elongation factor 2
60S ribosomal protein L18
beta-actin-like protein 2
60S acidic ribosomal protein P0
myosin-9
H2A histone family, member V
40S ribosomal protein S3a
small nuclear ribonucleoprotein Sm D1
CD81 antigen
CD9 antigen
anionic trypsin-1 precursor
protein FAM65B
programmed cell death 6-interacting protein
40S ribosomal protein S24
clathrin light chain A
40S ribosomal protein S7
eukaryotic translation initiation factor 3 subunit F
keratin, type II cytoskeletal 2 epidermal
ferritin heavy chain
serine/arginine-rich splicing factor 2
syntenin-1
baculoviral IAP repeat-containing protein 6
biglycan precursor
40S ribosomal protein S14
40S ribosomal protein S28
carbamoyl-phosphate synthase [ammonia], mitochondrial precursor
PREDICTED: acyl-coenzyme A thioesterase 12 isoform X1

126

Psmd6
Krt5
Krt6a
Lamb1
Ssb
Rplp1
Hsp90ab1
Anxa11
Psmd2
Hist1h1e
Eef2
Rpl18
Actbl2
Rplp0
Myh9
H2afv
Rps3a
Snrpd1
Cd81
Cd9
Prss1
Fam65b
PDCD6IP
Rps24
Clta
Rps7
EIF3F
Krt2
Fth1
Srsf2
Sdcbp
BIRC6
Bgn
Rps14
Rps28
CPS1
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Table B.1

Index sequences for small libraries of SCN2.2 cell, exosomes and EDCM.
Index

Sequence

Index

Sequence

Index 1

ATCACG

Index 13

AGTCAA

Index 2

CGATGT

Index 14

AGTTCC

Index3

TTAGGC

Index15

ATGTCA

Index4

TGACCA

Index16

CCGTCC

Index5

ACAGTG

Index17

GTAGAG

Index6

GCCAAT

Index18

GTCCGC

Index7

GAGATC

Index19

GTGAAA

Index8

ACTTGA

Index20

GTGGCC

Index9

GATCAG

Index21

GTTTCG

Index10

TAGCTT

Index22

CGTACG

Index11

GGCTAC

Index23

GAGTGG

Index12

CTTGTA

Index24

GGTAGC
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Figure B.1

Unique read numbers of individual sample library.

129

Table B.2

Unique down-regulated DE miRNA in exosomes, compared to cells

miRNA ID
rno-miR-1b
rno-miR-451-3p
rno-miR-133b-3p
rno-miR-26a-3p
rno-miR-3548
rno-miR-3595
rno-miR-133a-3p
rno-miR-3571
rno-miR-449c-3p
rno-miR-3084c-3p
rno-miR-376a-5p
rno-miR-494-5p
rno-miR-741-3p
rno-miR-105
rno-miR-1912-3p
rno-miR-6327
rno-miR-190b-5p
rno-miR-142-5p
rno-miR-3561-3p
rno-miR-142-3p
rno-miR-377-3p
rno-miR-743a-3p
rno-miR-503-5p
rno-miR-1199-3p
rno-miR-743b-3p
rno-miR-181b-2-3p
rno-miR-465-3p
rno-miR-335
rno-miR-340-5p
rno-miR-873-3p
rno-miR-210-3p
rno-miR-3574
rno-miR-497-3p
rno-miR-34c-5p
rno-miR-103-3p
rno-miR-222-5p
rno-miR-20a-5p

logFC
-5.88412
-3.61563
-3.36866
-3.28426
-3.13381
-3.12110
-3.00411
-2.91392
-2.83475
-2.83117
-2.79688
-2.71576
-2.68175
-2.58630
-2.58432
-2.52698
-2.51370
-2.37229
-2.35999
-2.26319
-2.20112
-2.19172
-2.14677
-2.02310
-1.96985
-1.93944
-1.91029
-1.81714
-1.71224
-1.70714
-1.65164
-1.64261
-1.61599
-1.58974
-1.53459
-1.53186
-1.52245

Fold change
0.01693
0.08158
0.09681
0.10265
0.11393
0.11494
0.12464
0.13269
0.14017
0.14052
0.14390
0.15222
0.15585
0.16651
0.16674
0.17350
0.17511
0.19314
0.19479
0.20831
0.21747
0.21889
0.22582
0.24603
0.25528
0.26072
0.26604
0.28378
0.30519
0.30627
0.31828
0.32028
0.32624
0.33223
0.34518
0.34583
0.34809
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PValue
0.00000
0.00000
0.00000
0.00035
0.00702
0.00005
0.00000
0.00001
0.00673
0.00008
0.00035
0.00084
0.00000
0.00042
0.00652
0.00404
0.00000
0.00002
0.00027
0.00000
0.00807
0.00485
0.00000
0.00712
0.00003
0.00179
0.00861
0.00000
0.00000
0.00527
0.00001
0.00006
0.00811
0.00000
0.00000
0.00277
0.00001

FDR
0.00000
0.00001
0.00004
0.00351
0.03719
0.00060
0.00001
0.00009
0.03619
0.00095
0.00353
0.00701
0.00001
0.00396
0.03592
0.02506
0.00001
0.00026
0.00282
0.00000
0.04047
0.02889
0.00000
0.03748
0.00039
0.01382
0.04214
0.00002
0.00001
0.03096
0.00019
0.00074
0.04047
0.00000
0.00003
0.01937
0.00013

Table B.2 (Continued)
rno-let-7a-2-3p
rno-miR-673-3p
rno-miR-542-3p
rno-miR-450a-5p
rno-miR-362-5p
rno-miR-34b-5p
rno-miR-665
rno-miR-146b-3p
rno-miR-6315
rno-miR-148a-3p
rno-miR-98-5p

Table B.3

-1.51669
-1.48402
-1.46145
-1.45083
-1.38115
-1.33445
-1.31300
-1.30331
-1.05593
-1.02622
-1.01755

0.34949
0.35749
0.36313
0.36581
0.38391
0.39654
0.40248
0.40519
0.48099
0.49100
0.49395

0.00527
0.00847
0.00041
0.00000
0.00108
0.00040
0.00936
0.00437
0.00727
0.00013
0.00654

0.03096
0.04170
0.00391
0.00002
0.00888
0.00391
0.04465
0.02648
0.03773
0.00139
0.03592

Unique up-regulated DE miRNA in exosomes, compared to cells.

miRNA ID
rno-miR-22-5p
rno-miR-218a-5p
rno-miR-24-3p
rno-miR-378a-5p
rno-miR-24-2-5p
rno-miR-146b-5p
rno-miR-1843a-5p
rno-miR-148b-5p
rno-miR-217-5p
rno-miR-466b-5p
rno-miR-3120
rno-miR-224-5p
rno-let-7b-5p
rno-let-7c-5p
rno-miR-145-5p
rno-miR-27a-3p
rno-miR-3589
rno-miR-135a-5p
rno-miR-3084b-5p
rno-miR-191b
rno-miR-505-3p
rno-miR-201-5p
rno-miR-547-3p

logFC
1.04190
1.12445
1.15162
1.15800
1.16209
1.16764
1.17210
1.29109
1.37936
1.41410
1.45313
1.49460
1.59883
1.77574
1.82325
1.84167
1.86522
2.05823
2.07298
2.36477
2.46242
2.48118
2.70009

Fold change
2.05893
2.18019
2.22164
2.23148
2.23782
2.24644
2.25339
2.44713
2.60153
2.66494
2.73801
2.81786
3.02897
3.42414
3.53878
3.58425
3.64323
4.16474
4.20756
5.15069
5.51140
5.58355
6.49844
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PValue
0.00677
0.00678
0.00401
0.00288
0.00084
0.00003
0.00568
0.00263
0.00756
0.00004
0.00413
0.00002
0.00000
0.00000
0.00000
0.00000
0.01033
0.00000
0.00320
0.00124
0.00208
0.00825
0.00001

FDR
0.03619
0.03619
0.02506
0.01963
0.00701
0.00041
0.03259
0.01890
0.03870
0.00049
0.02539
0.00029
0.00001
0.00000
0.00000
0.00001
0.04747
0.00002
0.02088
0.01005
0.01523
0.04087
0.00015

Table B.4

Unique down-regulated DE miRNA in EDCM, compared to cells.

miRNA ID
rno-miR-27a-5p
rno-miR-465-5p
rno-miR-628
rno-miR-434-3p
rno-miR-92a-1-5p
rno-miR-6331
rno-miR-195-3p
rno-let-7c-1-3p
rno-miR-331-5p
rno-miR-9a-5p
rno-miR-347
rno-miR-452-3p
rno-miR-340-3p
rno-miR-1-3p
rno-miR-374-3p
rno-miR-598-3p
rno-let-7f-2-3p
rno-miR-21-3p
rno-miR-3570
rno-miR-181a-1-3p
rno-miR-3588
rno-miR-155-3p
rno-miR-30d-3p
rno-miR-148a-5p
rno-miR-1843a-3p
rno-miR-125b-5p
rno-let-7i-5p
rno-miR-26b-3p
rno-miR-338-5p
rno-miR-30b-3p
rno-miR-450b-5p
rno-miR-3559-5p

logFC
-4.78456
-4.77303
-4.61771
-4.01997
-3.01445
-2.98003
-2.89028
-2.71513
-2.32185
-2.11411
-2.10222
-2.02710
-1.90100
-1.85709
-1.77509
-1.60668
-1.57464
-1.53914
-1.51538
-1.48506
-1.47651
-1.37142
-1.32925
-1.29255
-1.26143
-1.20695
-1.17494
-1.16196
-1.15932
-1.14282
-1.12751
-1.12191

Fold change
0.03628
0.03657
0.04073
0.06164
0.12375
0.12674
0.13488
0.15229
0.20001
0.23099
0.23290
0.24535
0.26776
0.27603
0.29218
0.32835
0.33573
0.34409
0.34980
0.35723
0.35936
0.38651
0.39798
0.40823
0.41713
0.43318
0.44290
0.44691
0.44772
0.45287
0.45770
0.45949
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PValue
0.00000
0.00151
0.00390
0.02392
0.00000
0.00727
0.00000
0.00000
0.00004
0.00000
0.00013
0.00054
0.00000
0.00000
0.00000
0.00000
0.01585
0.00062
0.00002
0.00000
0.00000
0.00640
0.00229
0.00028
0.01168
0.00006
0.00001
0.00670
0.00608
0.00982
0.00008
0.00020

FDR
0.00000
0.00424
0.01004
0.04907
0.00000
0.01739
0.00000
0.00000
0.00015
0.00000
0.00044
0.00170
0.00000
0.00000
0.00000
0.00002
0.03409
0.00191
0.00008
0.00002
0.00000
0.01576
0.00618
0.00094
0.02597
0.00023
0.00003
0.01629
0.01511
0.02228
0.00029
0.00069

Table B.5

Unique up-regulated DE miRNA in EDCM, compared to cells.

miRNA ID
rno-miR-345-3p
rno-miR-298-5p
rno-miR-361-5p
rno-miR-19b-3p
rno-miR-219a-1-3p
rno-miR-15b-3p
rno-miR-423-3p
rno-miR-3473
rno-miR-449a-5p
rno-miR-505-5p
rno-miR-144-3p
rno-miR-181b-5p
rno-let-7b-3p
rno-miR-3590-5p
rno-miR-3586-3p
rno-miR-363-3p
rno-miR-182
rno-miR-192-5p
rno-miR-345-5p
rno-miR-130b-3p
rno-miR-652-3p
rno-miR-3560
rno-miR-6325
rno-miR-301a-3p
rno-miR-212-3p
rno-miR-485-5p
rno-miR-140-5p
rno-miR-3075
rno-miR-337-3p
rno-miR-196b-5p
rno-miR-342-5p
rno-miR-1247-3p
rno-miR-344a-3p
rno-miR-219a-5p
rno-miR-6314
rno-miR-18a-3p
rno-let-7d-3p

logFC
1.05770
1.06304
1.14808
1.14840
1.18282
1.18541
1.20523
1.21663
1.24114
1.24898
1.30776
1.31654
1.33960
1.34231
1.34263
1.36274
1.36925
1.40817
1.41787
1.42808
1.44935
1.45107
1.52083
1.52205
1.53076
1.55537
1.55951
1.56612
1.56650
1.59777
1.61966
1.62020
1.62761
1.66000
1.66319
1.68931
1.70372

Fold change
2.08160
2.08932
2.21619
2.21669
2.27020
2.27429
2.30574
2.32403
2.36385
2.37673
2.47557
2.49068
2.53081
2.53557
2.53614
2.57173
2.58337
2.65399
2.67191
2.69088
2.73085
2.73411
2.86955
2.87199
2.88938
2.93909
2.94753
2.96108
2.96185
3.02676
3.07303
3.07418
3.09001
3.16016
3.16716
3.22502
3.25739
133

PValue
0.00605
0.01425
0.00045
0.01427
0.00719
0.00093
0.00140
0.00338
0.00002
0.01080
0.00945
0.00000
0.00234
0.00644
0.00037
0.00001
0.00002
0.00001
0.00209
0.00002
0.00000
0.01395
0.01035
0.00010
0.01467
0.00610
0.00000
0.00731
0.00232
0.00001
0.00163
0.02238
0.00832
0.00077
0.01308
0.01600
0.00000

FDR
0.01511
0.03130
0.00144
0.03130
0.01724
0.00273
0.00397
0.00881
0.00007
0.02423
0.02172
0.00002
0.00628
0.01581
0.00120
0.00006
0.00007
0.00004
0.00574
0.00007
0.00000
0.03077
0.02330
0.00036
0.03199
0.01511
0.00000
0.01739
0.00625
0.00003
0.00454
0.04627
0.01953
0.00230
0.02902
0.03425
0.00001

Table B.5 (Continued)
rno-miR-92a-3p
rno-miR-29c-5p
rno-miR-466b-2-3p
rno-miR-1306-5p
rno-miR-330-3p
rno-miR-466d
rno-let-7f-1-3p
rno-miR-497-5p
rno-miR-542-5p
rno-miR-760-3p
rno-miR-410-5p
rno-miR-499-3p
rno-miR-132-3p
rno-miR-144-5p
rno-miR-122-3p
rno-miR-219a-2-3p
rno-miR-3594-3p
rno-miR-484
rno-miR-320-5p
rno-miR-412-5p
rno-miR-200c-3p
rno-miR-30b-5p
rno-miR-125a-3p
rno-miR-138-5p
rno-miR-338-3p
rno-miR-384-3p
rno-miR-188-5p
rno-miR-92b-3p
rno-miR-208b-3p
rno-miR-93-3p
rno-miR-215
rno-miR-324-5p
rno-miR-448-3p
rno-miR-3064-3p
rno-miR-433-3p
rno-miR-410-3p
rno-miR-301b-3p
rno-miR-7578

1.70452
1.77274
1.77512
1.80806
1.80922
1.81126
1.81580
1.83736
1.85045
1.87017
1.87348
1.92098
1.93807
1.94807
1.97621
2.00268
2.03342
2.04458
2.04942
2.05134
2.06656
2.09183
2.09943
2.10036
2.11207
2.13704
2.15347
2.15708
2.15827
2.18713
2.21293
2.21537
2.21865
2.22605
2.27559
2.27750
2.28915
2.29498

3.25920
3.41702
3.42267
3.50171
3.50453
3.50948
3.52054
3.57356
3.60612
3.65574
3.66416
3.78680
3.83192
3.85858
3.93458
4.00743
4.09375
4.12553
4.13939
4.14491
4.18887
4.26289
4.28539
4.28816
4.32310
4.39859
4.44896
4.46010
4.46379
4.55399
4.63617
4.64402
4.65459
4.67851
4.84195
4.84837
4.88768
4.90748
134

0.00000
0.00128
0.00116
0.00018
0.00001
0.00063
0.01854
0.00015
0.00019
0.00012
0.00005
0.00872
0.00000
0.00010
0.00887
0.01468
0.00585
0.00000
0.00297
0.01602
0.01963
0.00000
0.00000
0.00000
0.00008
0.01542
0.00000
0.00000
0.00656
0.00001
0.00005
0.00000
0.00051
0.00001
0.01949
0.00055
0.00000
0.00046

0.00000
0.00367
0.00336
0.00063
0.00005
0.00195
0.03898
0.00052
0.00065
0.00041
0.00021
0.02040
0.00000
0.00036
0.02063
0.03199
0.01469
0.00000
0.00784
0.03425
0.04093
0.00000
0.00000
0.00000
0.00029
0.03342
0.00000
0.00000
0.01600
0.00003
0.00020
0.00000
0.00160
0.00004
0.04085
0.00171
0.00002
0.00147

Table B.5 (Continued)
rno-miR-16-5p
rno-miR-16-3p
rno-miR-29c-3p
rno-miR-15a-5p
rno-miR-328a-3p
rno-miR-702-5p
rno-miR-336-3p
rno-miR-3546
rno-miR-742-3p
rno-miR-147
rno-miR-425-3p
rno-miR-7a-2-3p
rno-miR-1306-3p
rno-miR-329-5p
rno-miR-19b-1-5p
rno-miR-325-3p
rno-miR-409b
rno-miR-107-5p
rno-miR-375-5p
rno-miR-541-3p
rno-miR-667-5p
rno-miR-3102
rno-miR-421-3p
rno-miR-3566
rno-miR-758-5p
rno-miR-582-5p
rno-miR-128-1-5p
rno-miR-3568
rno-miR-1224
rno-miR-743b-5p
rno-miR-296-3p
rno-miR-186-3p
rno-miR-378b
rno-miR-493-5p
rno-miR-214-5p
rno-miR-192-3p
rno-miR-193a-3p
rno-miR-32-3p

2.30572
2.31521
2.32168
2.34999
2.35117
2.37225
2.38569
2.41054
2.41596
2.42273
2.42728
2.42915
2.43786
2.44544
2.46501
2.46683
2.47328
2.51462
2.53852
2.53967
2.54020
2.56988
2.58290
2.60622
2.61733
2.64959
2.66996
2.67458
2.67985
2.70464
2.70901
2.71229
2.74586
2.78342
2.78827
2.80630
2.81958
2.82073

4.94413
4.97676
4.99914
5.09820
5.10239
5.17749
5.22592
5.31675
5.33675
5.36183
5.37879
5.38576
5.41838
5.44692
5.52133
5.52827
5.55306
5.71447
5.80992
5.81455
5.81668
5.93761
5.99145
6.08905
6.13611
6.27487
6.36414
6.38454
6.40791
6.51894
6.53871
6.55363
6.70791
6.88482
6.90802
6.99487
7.05955
7.06518
135

0.00000
0.00776
0.00000
0.00002
0.00000
0.00284
0.01141
0.00032
0.02217
0.00010
0.00000
0.00446
0.00008
0.00056
0.00066
0.00047
0.00117
0.00209
0.00031
0.00729
0.00018
0.00002
0.00001
0.00156
0.00074
0.00000
0.00001
0.01118
0.00000
0.00000
0.00000
0.00000
0.00212
0.00036
0.00121
0.00029
0.00000
0.00000

0.00001
0.01833
0.00000
0.00008
0.00000
0.00752
0.02545
0.00106
0.04596
0.00037
0.00000
0.01137
0.00029
0.00175
0.00202
0.00149
0.00336
0.00574
0.00105
0.01739
0.00063
0.00009
0.00005
0.00437
0.00223
0.00000
0.00006
0.02501
0.00001
0.00002
0.00000
0.00000
0.00579
0.00116
0.00346
0.00097
0.00000
0.00001

Table B.5 (Continued)
rno-miR-25-5p
rno-miR-219b
rno-miR-539-5p
rno-miR-323-3p
rno-miR-375-3p
rno-miR-149-5p
rno-miR-450a-3p
rno-miR-154-5p
rno-miR-153-3p
rno-miR-376c-3p
rno-miR-154-3p
rno-miR-1188-5p
rno-miR-181c-5p
rno-miR-208a-5p
rno-miR-181d-3p
rno-miR-343
rno-miR-540-3p
rno-miR-664-2-5p
rno-miR-666-3p
rno-miR-325-5p
rno-miR-3542
rno-miR-365-3p
rno-miR-294
rno-miR-214-3p
rno-miR-671
rno-miR-1896
rno-miR-31a-3p
rno-miR-187-5p
rno-miR-489-5p
rno-miR-1247-5p
rno-miR-411-5p
rno-miR-19b-2-5p
rno-miR-3068-3p
rno-miR-935
rno-miR-23b-5p
rno-miR-369-5p
rno-miR-6319
rno-miR-350

2.83087
2.85116
2.89203
2.91675
2.92672
2.93729
2.96252
2.97053
3.04593
3.05043
3.05503
3.05521
3.06628
3.06880
3.07601
3.09528
3.10083
3.12320
3.17000
3.17057
3.21248
3.21686
3.26083
3.27273
3.27529
3.31107
3.36989
3.39178
3.39848
3.41437
3.42219
3.44661
3.45096
3.47408
3.48439
3.49196
3.49512
3.50013

7.11505
7.21583
7.42315
7.55141
7.60382
7.65969
7.79485
7.83826
8.25879
8.28458
8.31105
8.31206
8.37610
8.39077
8.43276
8.54619
8.57914
8.71319
9.00049
9.00400
9.26941
9.29764
9.58532
9.66476
9.68187
9.92502
10.33805
10.49610
10.54492
10.66172
10.71970
10.90270
10.93561
11.11224
11.19199
11.25081
11.27552
11.31472
136

0.00000
0.00084
0.00250
0.00198
0.00085
0.00000
0.00000
0.01684
0.00113
0.00948
0.02302
0.00000
0.00000
0.00677
0.01836
0.00134
0.00000
0.00000
0.00485
0.00034
0.00000
0.00000
0.00220
0.00000
0.00000
0.00000
0.00000
0.00003
0.00001
0.00000
0.01586
0.00000
0.00000
0.00085
0.00000
0.00000
0.00062
0.00000

0.00000
0.00250
0.00666
0.00548
0.00250
0.00000
0.00000
0.03569
0.00329
0.02172
0.04746
0.00001
0.00000
0.01639
0.03871
0.00381
0.00000
0.00000
0.01226
0.00111
0.00000
0.00000
0.00597
0.00000
0.00000
0.00002
0.00000
0.00012
0.00003
0.00000
0.03409
0.00000
0.00000
0.00250
0.00000
0.00000
0.00191
0.00000

Table B.5 (Continued)
rno-miR-463-5p
rno-miR-299a-5p
rno-miR-365-5p
rno-miR-6328
rno-miR-200a-3p
rno-miR-193b-5p
rno-miR-23a-5p
rno-miR-7a-5p
rno-miR-7b
rno-miR-291a-5p
rno-miR-138-2-3p
rno-miR-664-1-5p
rno-miR-339-5p
rno-miR-1956-5p
rno-miR-762
rno-miR-136-3p
rno-miR-3084a-5p
rno-miR-137-3p
rno-miR-329-3p
rno-miR-128-2-5p
rno-miR-652-5p
rno-miR-291b
rno-miR-3572
rno-miR-504
rno-miR-327
rno-miR-883-3p
rno-miR-3576
rno-miR-351-3p
rno-miR-20a-3p
rno-miR-299a-3p
rno-miR-875
rno-miR-3550
rno-miR-3592
rno-miR-495
rno-miR-494-3p
rno-miR-1949
rno-miR-877
rno-miR-3551-3p

3.50064
3.50409
3.55502
3.56458
3.57931
3.60433
3.60650
3.61538
3.67425
3.71771
3.74018
3.75242
3.76035
3.80079
3.82140
3.82177
3.85022
3.85151
3.86244
3.87277
3.87413
3.91113
3.92079
3.97838
3.97863
4.04364
4.04370
4.04768
4.05795
4.09810
4.11073
4.14513
4.16065
4.18890
4.31092
4.33312
4.39017
4.41422

11.31875
11.34584
11.75354
11.83163
11.95309
12.16215
12.18053
12.25566
12.76611
13.15651
13.36310
13.47696
13.55125
13.93646
14.13701
14.14056
14.42223
14.43509
14.54488
14.64944
14.66320
15.04417
15.14525
15.76200
15.76473
16.49143
16.49208
16.53767
16.65573
17.12576
17.27633
17.69322
17.88465
18.23837
19.84793
20.15578
20.96876
21.32127
137

0.00322
0.00000
0.00100
0.00002
0.00000
0.00157
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00001
0.00000
0.00006
0.00003
0.00000
0.00017
0.00001
0.00145
0.00000
0.00002
0.00000
0.00000
0.00003
0.00000
0.00704
0.00000
0.00000
0.00387
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000

0.00844
0.00001
0.00292
0.00007
0.00002
0.00440
0.00000
0.00000
0.00001
0.00000
0.00000
0.00000
0.00004
0.00000
0.00023
0.00012
0.00000
0.00059
0.00003
0.00410
0.00000
0.00007
0.00001
0.00000
0.00014
0.00000
0.01695
0.00000
0.00000
0.01002
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000

Table B.5 (Continued)
rno-miR-598-5p
rno-miR-377-5p
rno-miR-218a-1-3p
rno-miR-1188-3p
rno-miR-3577
rno-miR-19a-5p
rno-miR-874-3p
rno-miR-149-3p
rno-miR-127-3p
rno-miR-702-3p
rno-miR-295-5p
rno-miR-5132-3p
rno-miR-1199-5p
rno-miR-3541
rno-miR-615
rno-miR-3585-3p
rno-miR-3547
rno-miR-323-5p
rno-miR-129-2-3p
rno-miR-6323
rno-miR-200b-5p
rno-miR-328a-5p
rno-miR-1843b-3p
rno-miR-326-5p
rno-miR-3561-5p
rno-miR-409a-5p
rno-miR-5132-5p
rno-miR-1249
rno-miR-881-3p
rno-miR-299b-5p
rno-miR-6322
rno-miR-483-3p
rno-miR-344g
rno-miR-341
rno-miR-675-5p
rno-miR-880-5p
rno-miR-6317
rno-miR-185-3p

4.55856
4.60082
4.61786
4.62408
4.62957
4.65681
4.67407
4.69425
4.73862
4.74058
4.93786
4.95249
5.02382
5.02604
5.03652
5.05542
5.06750
5.11498
5.11782
5.24603
5.33279
5.38070
5.40886
5.50597
5.54769
5.62360
5.62581
5.62747
5.72321
5.87980
6.14877
6.20088
6.35170
6.35449
6.53641
6.54119
6.67512
6.75943

23.56483
24.26531
24.55361
24.65964
24.75369
25.22552
25.52905
25.88863
26.69732
26.73349
30.65102
30.96330
32.53265
32.58283
32.82041
33.25316
33.53280
34.65467
34.72293
37.95018
40.30230
41.66308
42.48428
45.44246
46.77565
49.30305
49.37832
49.43515
52.82707
58.88383
70.95188
73.56148
81.66782
81.82622
92.82297
93.13114
102.19076
108.34078
138

0.00000
0.00000
0.00000
0.00000
0.00043
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00014
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00002
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000

0.00001
0.00000
0.00000
0.00000
0.00139
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00048
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00008
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000

Table B.5 (Continued)
rno-miR-369-3p
rno-miR-3543
rno-miR-370-3p
rno-miR-3573-3p
rno-miR-3591
rno-miR-216a-3p
rno-miR-434-5p
rno-miR-871-3p
rno-miR-770-3p
rno-miR-539-3p
rno-miR-3558-5p

6.76426
6.80880
6.93688
6.94558
7.00174
7.02505
7.04380
7.63046
7.75198
7.95491
8.38939

108.70406
112.11241
122.52079
123.26166
128.15485
130.24229
131.94542
198.15175
215.56533
248.12340
335.31890
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0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000

0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000

